About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Hormonal therapy
- Company
- University of Colorado, Denver
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 241 recruiting
Efficacy results: Not yet reported
241 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 9, 2026
Find a Clinical Trial Near Me
See recruiting studies for Hormonal therapy and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01072825
A European Network for the Investigation of Gender Incongruence
University Hospital, Ghent 125 participants Est. completion 2030-12-31 4 sitesOther conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual PersonsView official trial listing → -
Recruiting NCT NCT02476786
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 siteOther conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the BreastView official trial listing → -
Recruiting NCT NCT02535221
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
Not yet reported Peking University 234 participants Est. completion 2026-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT02641769
Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.
Not yet reported, Not yet reported Stem Cells Arabia 600 participants Est. completion 2031-01 1 siteOther conditions: Non-obstructive AzoospermiaView official trial listing → -
Recruiting NCT NCT03621904
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Radboud University Medical Center 150 participants Est. completion 2027-09-01 1 siteOther conditions: Endometrial Cancer Stage III, Endometrial Cancer Stage IV, Endometrial Cancer RecurrentView official trial listing → -
Recruiting NCT NCT03675893
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
Not yet reported Dana-Farber Cancer Institute 110 participants Est. completion 2031-08-01 3 sites Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Recruiting NCT NCT03808337
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Not yet reported Memorial Sloan Kettering Cancer Center 145 participants Est. completion 2027-01 12 sitesOther conditions: Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer, Metastatic Non-Small Cell Lung CarcinomaView official trial listing → -
Recruiting NCT NCT04158843
Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis
Not yet reported xuexin he 183 participants Est. completion 2026-12-31 4 sitesOther conditions: Breast Cancer, OligometastasisView official trial listing → -
Recruiting NCT NCT04174352
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2027-12 2 sitesOther conditions: ERα+ Breast Cancer, ESR1 Gene MutationView official trial listing → -
Recruiting NCT NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Not yet reported Amgen 479 participants Est. completion 2032-03-21 57 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT04293796
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)
Not yet reported N.N. Petrov National Medical Research Center of Oncology 60 participants Est. completion 2028-12-10 1 siteOther conditions: Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBView official trial listing → -
Recruiting NCT NCT04297020
Brain Health in Breast Cancer Survivors
Jonsson Comprehensive Cancer Center 120 participants Est. completion 2028-03-15 1 siteOther conditions: Cognitive Impairment, Cognitive FunctionView official trial listing → -
Recruiting NCT NCT04362046
Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia
Not yet reported Vancouver Coastal Health Research Institute 30 participants Est. completion 2028-07 1 siteOther conditions: Endometrial Hyperplasia, Endometrial Cancer, Gynecologic CancerView official trial listing → -
Recruiting NCT NCT04457895
Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.
Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 108 participants Est. completion 2028-08 7 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04476485
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04483804
Application of Radiomics in Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 2000 participants Est. completion 2028-12 1 siteOther conditions: Breast Cancer, Ultrasound, Elastography, Pathology, RadiomicsView official trial listing → -
Recruiting NCT NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Not yet reported Pfizer 320 participants Est. completion 2029-08-27 43 sitesOther conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT04666961
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
Not yet reported Institut Cancerologie de l'Ouest 262 participants Est. completion 2033-08-01 8 sitesOther conditions: Ductal Carcinoma in Situ, Extensive Disease, MastectomyView official trial listing → -
Recruiting NCT NCT04740697
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Not yet reported Institut Claudius Regaud 200 participants Est. completion 2028-02 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04775355
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
City of Hope Medical Center 30 participants Est. completion 2026-12-01 1 siteOther conditions: Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7View official trial listing → -
Recruiting NCT NCT04794075
Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer
Not yet reported Centre Hospitalier Emile Roux 300 participants Est. completion 2029-08 9 sitesOther conditions: Neoplasm of BreastView official trial listing → -
Recruiting NCT NCT04799535
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Mayo Clinic 550 participants Est. completion 2027-11-29 1 siteOther conditions: Breast Carcinoma, Breast NeoplasmView official trial listing → -
Recruiting NCT NCT04819243
PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
Not yet reported Samsung Medical Center 178 participants Est. completion 2027-12-31 1 siteOther conditions: Premenopausal HR+/HER2- Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT04838249
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
University of Leipzig 80 participants Est. completion 2026-05 1 siteOther conditions: Transsexualism, Transgenderism, Adiposity, Eating Behavior, Arterial Stiffness, MicroangiopathyView official trial listing → -
Recruiting NCT NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Not yet reported NRG Oncology 1670 participants Est. completion 2041-07 832 sitesOther conditions: Stage I Breast CancerView official trial listing → -
Recruiting NCT NCT04886531
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Not yet reported Ruth O'Regan 30 participants Est. completion 2027-12-21 4 sitesOther conditions: Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast CancerView official trial listing → -
Recruiting NCT NCT04921137
Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer
Not yet reported Ottawa Hospital Research Institute 500 participants Est. completion 2036-05 8 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04923542
SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 31 participants Est. completion 2027-12 2 sitesOther conditions: Brain Metastases, HR+ Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT04935164
Comparative Study of Gender Identity Disorder Versus Control
Centre Hospitalier Henri Laborit 120 participants Est. completion 2029-12 1 siteOther conditions: Gender Dysphoria, AdultView official trial listing → -
Recruiting NCT NCT04968964
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
Not yet reported Washington University School of Medicine 55 participants Est. completion 2030-09-30 1 siteOther conditions: Breast Cancer, Cancer of the BreastView official trial listing → -
Recruiting NCT NCT04985058
Real-world Data in Patients With Breast Cancer Treated With Abemaciclib
Hellenic Cooperative Oncology Group 108 participants Est. completion 2027-07-01 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sitesOther conditions: ER+ Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05063136
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
Not yet reported Henan Cancer Hospital 1979 participants Est. completion 2028-09 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05071105
SBRT in Early Breast Cancer in Elderly Women
Not yet reported University of Rome Tor Vergata 30 participants Est. completion 2026-12-31 1 siteOther conditions: Breast Neoplasm FemaleView official trial listing → -
Recruiting NCT NCT05169112
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
Not yet reported Ottawa Hospital Research Institute 72 participants Est. completion 2028-11 3 sitesOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT05169762
Feminizing Treatment in Transgender Women and Non-binary Persons
Odense University Hospital 100 participants Est. completion 2035-09-01 1 siteOther conditions: TransgenderismView official trial listing → -
Recruiting NCT NCT05212454
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 400 participants Est. completion 2029-12 1 siteOther conditions: Breast Cancer, Chemotherapy EffectView official trial listing → -
Recruiting NCT NCT05267912
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 152 participants Est. completion 2029-01-18 11 sites Stand-aloneOther conditions: Advanced, Pretreated Solid TumorsView official trial listing → -
Recruiting NCT NCT05280028
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 siteOther conditions: Menopausal SyndromeView official trial listing → -
Recruiting NCT NCT05304962
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Not yet reported Regor Pharmaceuticals Inc. 64 participants Est. completion 2027-03-31 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05335317
Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser
Not yet reported MeLSyTech, Ltd 120 participants Est. completion 2025-12-01 1 siteOther conditions: Postmenopausal Period, Vaginal Atrophy, Vaginal ProlapseView official trial listing → -
Recruiting NCT NCT05345860
Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300 participants Est. completion 2027-03-24 3 sitesOther conditions: Early-stage Breast CancerView official trial listing → -
Recruiting NCT NCT05362760
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sitesOther conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05417308
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 50 participants Est. completion 2027-12-31 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endocrine Therapy-Induced Alopecia, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT05442463
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
University of Calgary 200 participants Est. completion 2025-11-30 1 siteOther conditions: Hormone TherapyView official trial listing → -
Recruiting NCT NCT05448547
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Not yet reported Sven Löffeler 980 participants Est. completion 2036-12-31 26 sitesOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sitesOther conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05472792
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 siteOther conditions: Breast Cancer, Quality of LifeView official trial listing → -
Recruiting NCT NCT05534321
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
Not yet reported, Not yet reported Baptist Health South Florida 74 participants Est. completion 2028-09 1 siteOther conditions: Spine MetastasesView official trial listing → -
Recruiting NCT NCT05587751
Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients
Not yet reported Mayo Clinic 44 participants Est. completion 2027-07 1 siteOther conditions: Hormonal Gender-Affirming TherapyView official trial listing → -
Recruiting NCT NCT05603078
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2028-07 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT05621564
Pre-operative Therapy in Breast Cancer
RenJi Hospital 6032 participants Est. completion 2030-11 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05649605
Early Mental Response - The EMRE Study
Not yet reported Karolinska University Hospital 70 participants Est. completion 2026-12-30 1 siteOther conditions: Gender Dysphoria, Gender Identity, Gender IssuesView official trial listing → -
Recruiting NCT NCT05693766
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Not yet reported Sonya Reid 64 participants Est. completion 2037-08-31 4 sitesOther conditions: Invasive Mammary Carcinoma, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05717166
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Not yet reported David Palma 180 participants Est. completion 2029-04 5 sitesOther conditions: Metastatic TumorView official trial listing → -
Recruiting NCT NCT05720260
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Not yet reported National Taiwan University Hospital 42 participants Est. completion 2027-01-31 1 siteOther conditions: Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast CancerView official trial listing → -
Recruiting NCT NCT05726292
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Not yet reported University of Chicago 90 participants Est. completion 2028-04-01 4 sitesOther conditions: Prostate Cancer, Prostate AdenocarcinomaView official trial listing → -
Recruiting NCT NCT05759546
PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Not yet reported Fudan University 200 participants Est. completion 2027-06-01 1 siteOther conditions: Breast Cancer MetastaticView official trial listing → -
Recruiting NCT NCT05774951
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Not yet reported AstraZeneca 4300 participants Est. completion 2036-05-29 709 sitesOther conditions: Breast Cancer, Early Breast CancerView official trial listing → -
Recruiting NCT NCT05800535
JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients
Hospices Civils de Lyon 100 participants Est. completion 2029-02-10 1 siteOther conditions: Cancer, SarcopeniaView official trial listing → -
Recruiting NCT NCT05819853
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Not yet reported University of Colorado, Denver 80 participants Est. completion 2028-06-30 1 site Added to GLP-1Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, ObeseView official trial listing → -
Recruiting NCT NCT05860465
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 254 participants Est. completion 2026-12-30 22 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05872347
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 52 participants Est. completion 2026-12-31 25 sitesOther conditions: Breast Cancer Brain MetastasesView official trial listing → -
Recruiting NCT NCT05878314
Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer
University Hospital Tuebingen 504 participants Est. completion 2035-04 1 siteOther conditions: Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Not yet reported NRG Oncology 3960 participants Est. completion 2034-07 1261 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05891093
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Not yet reported Fudan University 766 participants Est. completion 2031-05-31 15 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05904964
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 288 participants Est. completion 2030-03-01 3 sitesOther conditions: HR Positive/HER2 Low Expression Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Not yet reported, Not yet reported DualityBio Inc. 862 participants Est. completion 2028-05 107 sitesOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT05919329
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
Not yet reported OHSU Knight Cancer Institute 80 participants Est. completion 2030-09-01 1 site Stand-aloneOther conditions: Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer, Prostate AdenocarcinomaView official trial listing → -
Recruiting NCT NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Not yet reported Fudan University 265 participants Est. completion 2028-01 1 siteOther conditions: Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05953090
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Not yet reported Stratpharma AG 2000 participants Est. completion 2028-12 14 sites Stand-aloneOther conditions: Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)View official trial listing → -
Recruiting NCT NCT05983107
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2027-07-15 1 siteOther conditions: HR+/HER2- Advanced Breast Cancer, Targeted TherapyView official trial listing → -
Recruiting NCT NCT06033287
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
Hunan Cancer Hospital 300 participants Est. completion 2025-12-31 1 siteOther conditions: Breast Cancer, Endocrine Therapy, CDK4/6 Inhibitors, Subsequent TreatmentView official trial listing → -
Recruiting NCT NCT06044623
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Not yet reported Region Örebro County 495 participants Est. completion 2029-05-31 12 sitesOther conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life, Toxicity, Older PatientsView official trial listing → -
Recruiting NCT NCT06075953
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Not yet reported QuantumLeap Healthcare Collaborative 400 participants Est. completion 2033-11 30 sitesOther conditions: Ductal Carcinoma in SituView official trial listing → -
Recruiting NCT NCT06083766
Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People
Mayo Clinic 24 participants Est. completion 2030-07 1 siteOther conditions: Effects of GAHT, on Skeletal Muscle in TGDView official trial listing → -
Recruiting NCT NCT06106477
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
Not yet reported Medical College of Wisconsin 20 participants Est. completion 2027-07-15 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06106529
REDucing Hot FLASHes in Women Using Endocrine Therapy.
Not yet reported Reinier de Graaf Groep 260 participants Est. completion 2029-01-01 1 siteOther conditions: Breast Cancer, Hot Flash Due to MedicationView official trial listing → -
Recruiting NCT NCT06111313
The University of Miami Adapt (UAdapt) Trial
Not yet reported University of Miami 130 participants Est. completion 2033-11-30 1 siteOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT06127979
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2028-11 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06130995
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Not yet reported University of Oklahoma 46 participants Est. completion 2030-01 1 site Stand-aloneOther conditions: Androgen Deprivation Therapy, Locally Advanced Prostate CancerView official trial listing → -
Recruiting NCT NCT06135714
Metastasis-directed Therapy for Oligometastases of Breast Cancer
Not yet reported Tokyo Medical and Dental University 146 participants Est. completion 2035-10-31 1 siteOther conditions: Breast Cancer, Oligometastasis, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06149130
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
Not yet reported Tongji Hospital 82 participants Est. completion 2026-11-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06162559
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Not yet reported The Netherlands Cancer Institute 30 participants Est. completion 2036-05 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06176534
Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Not yet reported Henan Cancer Hospital 240 participants Est. completion 2026-12-20 1 siteOther conditions: Advanced Breast Cancer, Treatment, HR Low/HER2 NegativeView official trial listing → -
Recruiting NCT NCT06195709
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
Not yet reported Institut Curie 300 participants Est. completion 2030-09-27 21 sitesOther conditions: Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06207734
Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 120 participants Est. completion 2028-07-10 13 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06218303
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 siteOther conditions: Ductal Carcinoma in SituView official trial listing → -
Recruiting NCT NCT06242509
Intestinal Akkermansia Muciniphila in Prostate Cancer
Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2027-01-20 1 siteOther conditions: Metastatic Castration-resistant Prostate CancerView official trial listing → -
Recruiting NCT NCT06245681
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Medical University of Vienna 40 participants Est. completion 2028-10-20 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Recruiting NCT NCT06280560
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Fundación IVI 60 participants Est. completion 2026-12-30 1 siteOther conditions: Endometrial ReceptivityView official trial listing → -
Recruiting NCT NCT06291675
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Medical University of Vienna 50 participants Est. completion 2033-03-03 1 siteOther conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic ChangeView official trial listing → -
Recruiting NCT NCT06306612
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
Not yet reported RenJi Hospital 192 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT06331676
Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care
Not yet reported Hospices Civils de Lyon 90 participants Est. completion 2028-03-21 2 sitesOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06341894
Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 1163 participants Est. completion 2029-06 1 siteOther conditions: Early Breast CancerView official trial listing → -
Recruiting NCT NCT06350825
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Not yet reported The First Affiliated Hospital with Nanjing Medical University 200 participants Est. completion 2028-12-31 1 siteOther conditions: Metastatic Prostate Cancer, Therapy, Directly ObservedView official trial listing → -
Recruiting NCT NCT06361940
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Not yet reported Medical College of Wisconsin 185 participants Est. completion 2028-12 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06369285
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Not yet reported Puma Biotechnology, Inc. 225 participants Est. completion 2029-06-30 53 sitesOther conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast CancerView official trial listing → -
Recruiting NCT NCT06375798
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
Hebei Medical University Fourth Hospital 620 participants Est. completion 2026-11-19 1 siteOther conditions: Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT06377852
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Not yet reported American Society of Clinical Oncology 500 participants Est. completion 2028-09-01 92 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06382948
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Not yet reported MedSIR 300 participants Est. completion 2028-04 104 sitesOther conditions: Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene MutationView official trial listing → -
Recruiting NCT NCT06383026
Individuals on Hormone Therapy Breast Cancer Screening Pilot
Medical College of Wisconsin 130 participants Est. completion 2028-02 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06413381
Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250 participants Est. completion 2029-11-28 1 siteOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06417801
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
AstraZeneca 170 participants Est. completion 2027-12-30 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06439290
Voice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty
Not yet reported University Ghent 290 participants Est. completion 2027-12 2 sitesOther conditions: Surgery, Larynx, Transgenderism, Gender DysphoriaView official trial listing → -
Recruiting NCT NCT06446401
The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer
Uppsala University 1400 participants Est. completion 2031-12-31 2 sitesOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT06461650
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
Not yet reported University of Florida 20 participants Est. completion 2029-03 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06461793
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
Not yet reported Samsung Medical Center 33 participants Est. completion 2033-12-31 1 siteOther conditions: High Risk Prostate CarcinomaView official trial listing → -
Recruiting NCT NCT06480513
Cancer Of the BReast Asanas Study (COBRA)
Not yet reported UMC Utrecht 140 participants Est. completion 2027-06 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06486883
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
Not yet reported MedSIR 200 participants Est. completion 2028-01 79 sitesOther conditions: Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06500169
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Not yet reported University of Southern California 20 participants Est. completion 2027-12-31 2 sitesOther conditions: Localized Prostate Carcinoma, Locally Advanced Prostate Carcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT06517212
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Not yet reported Baylor Research Institute 48 participants Est. completion 2030-12-31 1 siteOther conditions: Breast Cancer, Breast Neoplasms, Breast CancersView official trial listing → -
Recruiting NCT NCT06530459
The MUSE Study for Menopausal Arthralgia
Not yet reported, Not yet reported National University Hospital, Singapore 100 participants Est. completion 2028-04 1 siteOther conditions: Arthralgia, Menopause, Perimenopausal Disorder, Joint Pain, Postmenopausal DisorderView official trial listing → -
Recruiting NCT NCT06548919
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
SciClone Pharmaceuticals 450 participants Est. completion 2027-12-31 1 siteOther conditions: ESR1 Gene Mutation, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06590857
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Not yet reported, Not yet reported RayzeBio, Inc. 64 participants Est. completion 2033-11 31 sitesOther conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast CancerView official trial listing → -
Recruiting NCT NCT06637150
Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
Not yet reported Fudan University 1388 participants Est. completion 2030-09-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06670053
Puberty, Testosterone, and Brain Development
University of Colorado, Denver 100 participants Est. completion 2029-01 1 siteOther conditions: Gender Identity, Gender Dysphoria in Adolescents and Adults, Headache, TransgenderView official trial listing → -
Recruiting NCT NCT06680596
Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
Not yet reported UNICANCER 80 participants Est. completion 2029-08-01 40 sitesOther conditions: Breast Cancer Metastatic, Breast Cancer Stage IVView official trial listing → -
Recruiting NCT NCT06702995
Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Not yet reported, Not yet reported Evopoint Biosciences Inc. 307 participants Est. completion 2027-07-13 2 sitesOther conditions: Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)View official trial listing → -
Recruiting NCT NCT06704516
COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
Not yet reported University of Oxford 10 participants Est. completion 2026-01-01 1 siteMASLD Other conditions: MenopauseView official trial listing → -
Recruiting NCT NCT06726148
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sitesOther conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT06757634
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 239 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06774053
Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - The SPECTRA Study
University Hospital, Basel, Switzerland 600 participants Est. completion 2046-01 3 sitesOther conditions: Transgender Individuals, Gender IncongruenceView official trial listing → -
Recruiting NCT NCT06776458
Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
University of Toronto 112 participants Est. completion 2026-09-30 1 siteOther conditions: Breast Cancer FemalesView official trial listing → -
Recruiting NCT NCT06781762
Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
University of Toronto 40 participants Est. completion 2026-12-30 1 siteOther conditions: Breast Cancer FemalesView official trial listing → -
Recruiting NCT NCT06781996
A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 180 participants Est. completion 2026-12-15 1 siteOther conditions: Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT06792201
Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not
Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-06-14 1 siteOther conditions: SarcopeniaView official trial listing → -
Recruiting NCT NCT06795243
Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates.
Not yet reported University of Seville 32 participants Est. completion 2026-07-01 1 siteOther conditions: Endometriosis, Endometriosis Related Pain, Endometriosis, Pain, Endometriosis-related Pain, Pain, Pain Intensity Assessment, Pain Management, Pain, Chronic Disease, Pain Score, Therapeutic Exercise, Exercise Adherence, Adherence, Treatment, Treatment Adherence and Compliance, Quality of LifeView official trial listing → -
Recruiting NCT NCT06806930
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Not yet reported George Washington University 90 participants Est. completion 2028-10 1 siteOther conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Carcinoma, BreastView official trial listing → -
Recruiting NCT NCT06807580
Progesterone in Gender Affirming Hormone Therapy Study
Not yet reported Emory University 40 participants Est. completion 2027-02 1 siteOther conditions: Transgender WomenView official trial listing → -
Recruiting NCT NCT06818682
Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial
Not yet reported Tata Memorial Centre 206 participants Est. completion 2035-01-01 1 siteOther conditions: Prostate CarcinomaView official trial listing → -
Recruiting NCT NCT06830720
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Novartis Pharmaceuticals 3250 participants Est. completion 2030-06-30 287 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT06843967
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2028-08-19 7 sitesObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT06856174
Menopausal HT for Women Living With HIV (HoT)
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 105 participants Est. completion 2027-09-20 23 sitesOther conditions: HIV Infection, MenopauseView official trial listing → -
Recruiting NCT NCT06864533
Adjuvant Chemotherapy for High Malignant Prostate Cancer
Peking University First Hospital 315 participants Est. completion 2031-09-01 3 sitesOther conditions: Prostate Cancer, Radiation Therapy, Chemotherapy, Gleason ScoreView official trial listing → -
Recruiting NCT NCT06897488
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
Not yet reported M.D. Anderson Cancer Center 300 participants Est. completion 2030-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06914440
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Not yet reported Xijing Hospital 27 participants Est. completion 2030-12 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06917313
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Not yet reported Yale University 92 participants Est. completion 2028-03 2 sitesOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT06931340
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Not yet reported Alliance for Clinical Trials in Oncology 1260 participants Est. completion 2039-05-08 214 sitesOther conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT06939257
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
University of Kansas Medical Center 200 participants Est. completion 2029-09-16 1 siteOther conditions: Pain, Gender Minority IndividualsView official trial listing → -
Recruiting NCT NCT06953882
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
Not yet reported Yale University 140 participants Est. completion 2030-09 1 siteOther conditions: HER2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT06970912
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
Not yet reported Peking University People's Hospital 393 participants Est. completion 2029-12-31 1 siteOther conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA Monitoring, Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT06975111
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites Stand-aloneOther conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, CardiovascularView official trial listing → -
Recruiting NCT NCT06979596
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sitesOther conditions: Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT06998407
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sitesOther conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07010939
A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
FangYi 3000 participants Est. completion 2028-12-31 3 sitesOther conditions: Breast Neoplasms, Quality of Life (QOL), Toxicities, Breast DiseasesView official trial listing → -
Recruiting NCT NCT07012720
Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer
Not yet reported Xijing Hospital 71 participants Est. completion 2027-04-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07019363
CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
Not yet reported Fudan University 1903 participants Est. completion 2033-04-15 1 siteOther conditions: Breast Cancer, Adjuvant TherapyView official trial listing → -
Recruiting NCT NCT07024173
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07032506
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
Not yet reported Weill Medical College of Cornell University 320 participants Est. completion 2031-12-31 3 sites Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Recruiting NCT NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Not yet reported Pfizer 400 participants Est. completion 2030-11-04 433 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07071038
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
Not yet reported Dartmouth-Hitchcock Medical Center 62 participants Est. completion 2027-08-05 1 siteOther conditions: Breast Cancer, Adjuvant Treatment, Early Stage Breast CancerView official trial listing → -
Recruiting NCT NCT07071337
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430 participants Est. completion 2031-02 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07077876
Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100 participants Est. completion 2026-01-20 1 siteOther conditions: Endometrial Adenocarcinoma, Endometrial Hyperplasia, Fertility Preservation, Conservative Treatment TherapyView official trial listing → -
Recruiting NCT NCT07084558
ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness
Not yet reported Austrian Breast & Colorectal Cancer Study Group 350 participants Est. completion 2033-06-30 14 sitesOther conditions: Early and Locally Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07106112
Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy
Not yet reported Saint Petersburg State University, Russia 110 participants Est. completion 2026-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07106632
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
Not yet reported UNICANCER 3380 participants Est. completion 2038-08-15 105 sitesOther conditions: Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07125950
SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer
Not yet reported Henan Cancer Hospital 30 participants Est. completion 2028-01-31 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07137871
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
Not yet reported The University of Texas Health Science Center at San Antonio 35 participants Est. completion 2028-10 1 site Stand-aloneOther conditions: Breast Cancer MetastaticView official trial listing → -
Recruiting NCT NCT07148921
Perception of Pain During Gender Affirming Hormone Therapy
Medical University of Vienna 40 participants Est. completion 2026-03 1 siteOther conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex HormonesView official trial listing → -
Recruiting NCT NCT07151911
Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients
Azienda Ospedaliero-Universitaria di Modena 100 participants Est. completion 2031-09 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07152340
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Not yet reported Shanghai Changzheng Hospital 64 participants Est. completion 2030-05-01 2 sitesOther conditions: Thyroid Associated OphthalmopathiesView official trial listing → -
Recruiting NCT NCT07152366
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
Not yet reported Shanghai Changzheng Hospital 96 participants Est. completion 2035-04-15 1 siteOther conditions: Thyroid Associated OphthalmopathiesView official trial listing → -
Recruiting NCT NCT07162987
Prehabilitation to Patients With Prostate Cancer
Not yet reported Odense University Hospital 20 participants Est. completion 2026-11 3 sitesOther conditions: Prostate Cancer (Diagnosis)View official trial listing → -
Recruiting NCT NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Not yet reported Eli Lilly and Company 800 participants Est. completion 2033-05 364 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Recruiting NCT NCT07180056
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Wenjin Yin 229 participants Est. completion 2033-02 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07190443
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Not yet reported Japanese Foundation for Cancer Research 290 participants Est. completion 2035-02-06 1 siteOther conditions: Breast Cancer, Locoregional Recurrence, Abemaciclib, Endocrine TherapyView official trial listing → -
Recruiting NCT NCT07205822
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Not yet reported AstraZeneca 100 participants Est. completion 2028-02-02 40 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Not yet reported Natera, Inc. 725 participants Est. completion 2037-12-30 49 sitesOther conditions: Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)View official trial listing → -
Recruiting NCT NCT07222215
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
Not yet reported Kristina A. Fanucci 297 participants Est. completion 2030-10-01 1 siteOther conditions: Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2- Breast Cancer, ESR1 Gene Mutation, ER Wildtype, Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT07235176
Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients
Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 300 participants Est. completion 2031-12-30 1 siteOther conditions: Advanced ER+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07237269
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Not yet reported University of Nebraska 140 participants Est. completion 2033-04-03 1 siteOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT07242118
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
Not yet reported University of Kansas Medical Center 18 participants Est. completion 2027-10 2 sites Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Recruiting NCT NCT07242391
Menopausal Hormone Therapy And Left Ventricular Function
Mayo Clinic 50 participants Est. completion 2027-12 1 siteOther conditions: Menopause, Left Ventricular DysfunctionView official trial listing → -
Recruiting NCT NCT07243002
Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
Novartis Pharmaceuticals 3000 participants Est. completion 2030-04-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07243834
Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise
Not yet reported Royal Marsden NHS Foundation Trust 160 participants Est. completion 2030-04-28 1 siteOther conditions: Prostate Cancer, Prostate Cancer (Diagnosis)View official trial listing → -
Recruiting NCT NCT07252726
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Not yet reported Ottawa Hospital Research Institute 50 participants Est. completion 2033-03 3 sitesOther conditions: Metastatic Breast Cancer, Metastatic Prostate CancerView official trial listing → -
Recruiting NCT NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals 205 participants Est. completion 2031-05-09 16 sitesOther conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate CancerView official trial listing → -
Recruiting NCT NCT07295457
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
Not yet reported Hospices Civils de Lyon 182 participants Est. completion 2029-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07330544
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
Not yet reported Zhejiang Cancer Hospital 118 participants Est. completion 2028-11-26 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07333521
Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.
Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2034-01-13 1 siteOther conditions: Isolated Non-acquired Growth Hormone DeficiencyView official trial listing → -
Recruiting NCT NCT07344779
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Bayer 1600 participants Est. completion 2030-06-30 16 sitesOther conditions: Metastatic Hormone-Sensitive Prostate CancerView official trial listing → -
Recruiting NCT NCT07347600
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 500 participants Est. completion 2029-12-31 32 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07349069
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
Not yet reported Shandong Suncadia Medicine Co., Ltd. 5500 participants Est. completion 2034-01 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07364071
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
Not yet reported University of California, San Diego 150 participants Est. completion 2034-04 1 siteOther conditions: Prostate AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07366112
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
Not yet reported Peking University People's Hospital 158 participants Est. completion 2029-12-31 1 siteOther conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA MonitoringView official trial listing → -
Recruiting NCT NCT07379918
Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer
Assistance Publique - Hôpitaux de Paris 1000 participants Est. completion 2031-06-28 1 siteOther conditions: Breast Cancer (Early Breast Cancer), Breast Cancer Survivors, Breast Cancer Prognostic, Early Hormone Receptor-positive (HR-positive), HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT07391774
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Not yet reported National Cancer Institute (NCI) 1978 participants Est. completion 2029-07-31 258 sitesOther conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07395804
How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany
Bayer 500 participants Est. completion 2031-02-15 1 siteOther conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)View official trial listing → -
Recruiting NCT NCT07400419
Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2028-04-01 1 siteOther conditions: Muscle Mass and StrengthView official trial listing → -
Recruiting NCT NCT07401381
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
Not yet reported Rovi Pharmaceuticals Laboratories 120 participants Est. completion 2028-10 21 sitesOther conditions: Hormone Receptor Positive Early Breast CancerView official trial listing → -
Recruiting NCT NCT07406412
Hormonal Regulation of Cardiometabolic Health Study
University of Jyvaskyla 120 participants Est. completion 2028-12-15 7 sitesOther conditions: Menopause SurgicalView official trial listing → -
Recruiting NCT NCT07407439
Real-world Studies of CDK4/6 Inhibitors
Tianjin Medical University Cancer Institute and Hospital 245 participants Est. completion 2027-06-01 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07407920
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
Not yet reported M.D. Anderson Cancer Center 120 participants Est. completion 2028-09-30 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma, Early Stage Triple-Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07410039
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 siteOther conditions: Neuromyelitis Optica Spectrum Disorder AttackView official trial listing → -
Recruiting NCT NCT07429773
Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP
Not yet reported Centre Hospitalier Universitaire de Nice 120 participants Est. completion 2028-04 1 siteOther conditions: Endometriosis, Chronic Pelvic Pain SyndromeView official trial listing → -
Recruiting NCT NCT07432178
CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon)
Not yet reported Fudan University 2288 participants Est. completion 2034-03-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07443774
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.
University Hospital, Grenoble 81 participants Est. completion 2031-12 1 siteOther conditions: ER+ Breast Cancer, Breast Cancer, Early Breast Cancer, Endocrine Therapy, Abemaciclib, RibociclibView official trial listing → -
Recruiting NCT NCT07454499
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
Not yet reported Abramson Cancer Center at Penn Medicine 60 participants Est. completion 2027-12-31 1 siteOther conditions: CancerView official trial listing → -
Recruiting NCT NCT07467330
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Not yet reported Fujian Cancer Hospital 258 participants Est. completion 2032-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07477626
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
Not yet reported Sun Yat-sen University 372 participants Est. completion 2038-12-31 13 sites Stand-aloneOther conditions: Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy, Lymph Node PositiveView official trial listing → -
Recruiting NCT NCT07483307
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 176 participants Est. completion 2030-03-13 7 sitesOther conditions: Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER+ Breast Cancer, Lobular Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07483658
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
Not yet reported CHU de Quebec-Universite Laval 434 participants Est. completion 2036-02 4 sites Stand-aloneOther conditions: Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy), Prostate Cancer, Prostatic Neoplasms, Neoplasm Recurrence, Local, Biochemical Recurrence of Malignant Neoplasm of ProstateView official trial listing → -
Recruiting NCT NCT07490938
Electroacupuncture vs. Auricular Acupressure vs. Waitlist Control for Breast Cancer Endocrine Therapy-Related Joint Pain
Not yet reported First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 200 participants Est. completion 2027-12 6 sitesOther conditions: Breast Cancer Survivors, Endocrine Therapy-Induced Joint PainView official trial listing → -
Recruiting NCT NCT07502820
The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER
Not yet reported Karolinska Institutet 1100 participants Est. completion 2036-08 4 sitesOther conditions: Breast Cancer, Adjuvant Drug TherapyView official trial listing → -
Recruiting NCT NCT07506876
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
Not yet reported Legacy Health System 30 participants Est. completion 2027-12 4 sitesOther conditions: Breast Cancer - Infiltrating Ductal Carcinoma, HER-2 Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07527689
Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer
Not yet reported Ruijin Hospital 1950 participants Est. completion 2039-03-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07563621
Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors
Jessa Hospital 264 participants Est. completion 2028-08-31 1 siteOther conditions: Genitourinary Syndrome of Menopause (GSM), Breast Cancer, Vulvovaginal Atrophy, Genitourinary Syndrome of MenopauseView official trial listing → -
Recruiting NCT NCT07578116
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Not yet reported SWOG Cancer Research Network 562 participants Est. completion 2033-05-31 59 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma, Oligometastatic Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07581834
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Not yet reported Fujian Cancer Hospital 2000 participants Est. completion 2032-06-30 2 sitesOther conditions: Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases, CDK4/6 Inhibitor, HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07592403
Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis
Not yet reported Beni-Suef University 60 participants Est. completion 2027-01-30 1 site Stand-aloneOther conditions: Endometriosis, Pulsed Electromagnetic Therapy, Trans Perineal UltrasoundView official trial listing → -
Recruiting NCT NCT07594002
Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy
Not yet reported University of Kentucky 40 participants Est. completion 2028-08-31 1 siteOther conditions: Accupuncture, Prostate Cancer, Hormone Therapy, Hot FlashesView official trial listing → -
Recruiting NCT NCT07597993
BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy
AstraZeneca 109 participants Est. completion 2029-03-31 9 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07604571
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2032-06-08 12 sitesOther conditions: Advanced HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07605728
Probiotics for Abemaciclib-Induced Abdominal Discomfort.
Not yet reported Leeuwenhoek Laboratories Co. Ltd. 80 participants Est. completion 2029-12-31 1 siteOther conditions: Breast Cancer, Chemotherapy-induced DiarrheaView official trial listing → -
Recruiting NCT NCT07610720
Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 57 participants Est. completion 2029-11-01 1 siteOther conditions: Advanced/Metastatic Breast Cancer, HER2-Positive Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07613151
Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study
Istituto Oncologico Veneto IRCCS 250 participants Est. completion 2027-12-31 1 siteOther conditions: Lobular Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07615751
Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer
Not yet reported Fudan University 502 participants Est. completion 2029-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07629206
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Not yet reported IceCure Medical Ltd. 400 participants Est. completion 2034-09 3 sitesOther conditions: Low-Risk, Early Stage Breast CancerView official trial listing → -
Recruiting NCT NCT07646171
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)
Tel-Aviv Sourasky Medical Center 19 participants Est. completion 2027-12-31 1 siteOther conditions: Hormone Receptor Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07661927
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Not yet reported UNICANCER 700 participants Est. completion 2033-07-06 41 sitesOther conditions: Breast Cancer (Early Breast Cancer)View official trial listing → -
Recruiting NCT NCT07666555
A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.
Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07671885
Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)
Not yet reported Tokyo Women's Medical University 950 participants Est. completion 2039-01-27 49 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07683754
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
Not yet reported Daiichi Sankyo 200 participants Est. completion 2030-08-28 5 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive, HR PositiveView official trial listing → -
Recruiting NCT NCT07706127
mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health
Not yet reported The University of Texas Health Science Center at San Antonio 159 participants Est. completion 2028-04-30 1 siteOther conditions: Treatment AdherenceView official trial listing → -
Recruiting NCT NCT07708194
Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure
Not yet reported, Not yet reported Tianjin Medical University Cancer Institute and Hospital 94 participants Est. completion 2027-02 1 siteOther conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-Positive Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07751133
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Not yet reported University College, London 1500 participants Est. completion 2033-08-01 4 sitesOther conditions: Prostate Cancer, mHSPC, mCRPCView official trial listing → -
Recruiting NCT NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery
Not yet reported Fudan University 636 participants Est. completion 2036-06 1 siteOther conditions: Ductal Carcinoma In Situ, DCISView official trial listing → -
Recruiting NCT NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery
Not yet reported Fudan University 234 participants Est. completion 2037-02 1 siteOther conditions: Ductal Carcinoma In Situ, DCISView official trial listing → -
Recruiting NCT NCT07796880
Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2033-03-15 1 siteOther conditions: Hormone Receptor-Positive Breast Cancer, HER2 Low Breast Carcinoma, Early-Stage Breast CancerView official trial listing → -
Recruiting NCT NCT07810959
Breast and Vascular Effects of Menopausal Hormone Therapy in Postmenopausal Women
Sanliurfa Mehmet Akif Inan Education and Research Hospital 120 participants Est. completion 2027-05-31 1 siteOther conditions: MenopauseView official trial listing → -
Recruiting NCT NCT07817056
Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient Adherence
Tianjin Medical University Cancer Institute and Hospital 100 participants Est. completion 2028-10-31 1 siteOther conditions: Breast Cancer, HyperglycemiaView official trial listing → -
Recruiting NCT NCT07827573
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
Not yet reported Hoffmann-La Roche 1500 participants Est. completion 2032-11-30 1 siteOther conditions: Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT07831902
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer
Not yet reported University College, London 600 participants Est. completion 2034-12 12 sitesOther conditions: Endometrial Cancer, Uterine NeoplasmsView official trial listing → -
Recruiting NCT NCT07848438
Sex Hormones and Aging
Not yet reported University of Michigan 120 participants Est. completion 2031-08 1 siteOther conditions: Menopause, Menopausal Hormone Therapy, AgingView official trial listing → -
Recruiting NCT NCT07856225
Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer
Fundación Santa Fe de Bogota 370 participants Est. completion 2027-06-01 1 siteOther conditions: Breast Neoplasms, Triple Negative Breast Neoplasms, HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07861295
Satavari and Ashoka for Menopause (SAM) Study
Not yet reported Vidya USA Corporation 50 participants Est. completion 2026-12-15 1 siteOther conditions: MenopauseView official trial listing → -
Recruiting NCT NCT07871110
Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Not yet reported TransThera Sciences (Nanjing), Inc. 182 participants Est. completion 2029-06-30 16 sitesOther conditions: Prostate Cancer (CRPC)View official trial listing → -
Recruiting NCT NCT07871435
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Not yet reported, Not yet reported GI Innovation, Inc. 107 participants Est. completion 2029-09-30 6 sitesOther conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)View official trial listing → -
Recruiting NCT NCT07893327
Evaluation of the Effect of Regular Physical Exercise in Breast Cancer.
Not yet reported Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares 150 participants Est. completion 2028-12 1 siteOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT07896772
Anti-Müllerian Hormone in Breast Cancer Clinical Practice
Masaryk Memorial Cancer Institute 200 participants Est. completion 2027-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00000399
Bone Estrogen Strength Training
Not yet reported University of Arizona 300 participants Est. completion 2001-01 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00000421
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
Not yet reported NYU Langone Health 154 participants Est. completion 2003-08 3 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00000601
Postmenopausal Hormone Therapy in Unstable Angina
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06Cardiovascular disease Other conditions: Angina, Unstable, Coronary Disease, Heart Diseases, PostmenopauseView official trial listing → -
Completed NCT NCT00001305
Growth Hormone Therapy in Osteogenesis Imperfecta
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 42 participants Est. completion 2017-05-19 1 siteOther conditions: Osteogenesis ImperfectaView official trial listing → -
Completed NCT NCT00001752
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 30 participants Est. completion 2000-07 1 siteOther conditions: Hypercholesterolemia, PostmenopauseView official trial listing → -
Completed NCT NCT00001890
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2001-03 1 siteOther conditions: Atherosclerosis, Chlamydia Infections, Cytomegalovirus Infections, Pneumonia, Bacterial, PostmenopauseView official trial listing → -
Completed NCT NCT00002597
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 2028 participants Est. completion 2018-05-14 239 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00002633
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
Not yet reported NCIC Clinical Trials Group 361 participants Est. completion 2012-01-06 15 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00002646
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
Not yet reported Eastern Cooperative Oncology Group 1500 participants 85 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002651
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Not yet reported SWOG Cancer Research Network 3040 participants Est. completion 2013-06 14 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00002855
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003026
Hormone Therapy in Treating Patients With Advanced Prostate Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 966 participants 17 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003124
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Not yet reported Herbert Irving Comprehensive Cancer Center 105 participants Est. completion 2007-01 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003323
Hormone Therapy in Treating Patients With Prostate Cancer
Not yet reported Alliance for Clinical Trials in Oncology 101 participants Est. completion 2010-03 43 sitesOther conditions: Prostate Cancer, Sexual Dysfunction and InfertilityView official trial listing → -
Completed NCT NCT00003391
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Weill Medical College of Cornell University 30 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003428
Hormone Therapy in Treating Women With Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 114 participants Est. completion 2001-06 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00003517
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Not yet reported Burzynski Research Institute 1 siteOther conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer, Recurrent Prostate CancerView official trial listing → -
Withdrawn NCT NCT00003622
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Not yet reported James Ahlgren Est. completion 2017-02-22 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003626
Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2000-05 3 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00003645
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2017-03-20 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003653
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Not yet reported NCIC Clinical Trials Group 1386 participants Est. completion 2013-01-10 29 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003669
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
Not yet reported Eli Lilly and Company Est. completion 2001-04 10 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00003670
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
Not yet reported Eli Lilly and Company Est. completion 2001-01 4 sitesOther conditions: Ovarian Cancer, Primary Peritoneal Cavity CancerView official trial listing → -
Status unknown NCT NCT00003734
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Not yet reported St. Luke's Hospital, Ireland 276 participants 12 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004001
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported SWOG Cancer Research Network 770 participants Est. completion 2007-01 16 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004054
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004124
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Not yet reported SWOG Cancer Research Network 983 participants Est. completion 2018-05-01 234 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004205
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 8028 participants Est. completion 2016-06-30 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00004635
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Not yet reported National Cancer Institute (NCI) 159 participants Est. completion 2010-03-30 9 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005044
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 1579 participants Est. completion 2022-05-20 261 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005515
Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
University of Washington Est. completion 2003-08Cardiovascular disease Other conditions: Venous Thromboembolism, PostmenopauseView official trial listing → -
Completed NCT NCT00005627
Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005805
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 1 siteOther conditions: Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00005810
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005828
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Alliance for Clinical Trials in Oncology 54 participants Est. completion 2008-06 16 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Eastern Cooperative Oncology Group 19 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005848
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Fox Chase Cancer Center 7 participants Est. completion 2007-05 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005857
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Not yet reported City of Hope Medical Center Est. completion 2002-10 4 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005947
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Dendreon 127 participants Est. completion 2004-09 34 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00005960
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Amgen 6 sitesOther conditions: Pain, Prostate CancerView official trial listing → -
Terminated NCT NCT00005983
S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer
Not yet reported SWOG Cancer Research Network 98 participants Est. completion 2005-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00005992
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Jonsson Comprehensive Cancer Center 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00006002
SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported University of Chicago 36 participants Est. completion 2006-01 18 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00006023
Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Swiss Cancer Institute Est. completion 2001-06 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00006044
Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
Not yet reported Memorial Sloan Kettering Cancer Center 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00006114
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 10 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00006143
Growth Hormone Treatment of Children With HIV-Associated Growth Failure
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 102 participants Est. completion 2002-07 20 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00006313
Hormone Therapy Effects on CVD Risk Factors
National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, PostmenopauseView official trial listing → -
Status unknown NCT NCT00009750
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported University of California, Davis 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00009945
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
Not yet reported NSABP Foundation Inc 3323 participants Est. completion 2012-12 17 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00010231
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported University of Pittsburgh 22 participants Est. completion 2002-11 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00015977
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported University of Chicago 13 participants Est. completion 2005-01 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00016341
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
Not yet reported Gynecologic Oncology Group 50 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00016393
BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported SWOG Cancer Research Network Est. completion 2006-04 28 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00016913
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Not yet reported Alliance for Clinical Trials in Oncology 34 participants Est. completion 2008-05 23 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00017576
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported OHSU Knight Cancer Institute 19 participants Est. completion 2006-07 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00021450
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 819 participants Est. completion 2016-01 20 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00025116
ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported NCIC Clinical Trials Group 40 participants Est. completion 2008-09-22 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00027859
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Eastern Cooperative Oncology Group 98 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00028769
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00030654
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 21 participants Est. completion 2005-02-04 78 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00033358
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Not yet reported National Cancer Institute (NCI) 52 participants 1 siteOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00034125
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Not yet reported Eli Lilly and Company 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT00036621
A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
Not yet reported Bristol-Myers Squibb 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00040755
BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported National Cancer Institute (NCI) 68 participants 1 siteOther conditions: Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT00041301
Assessing Quality of Life of Patients With Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 625 participants Est. completion 2005-11 33 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Not yet reported Nuvance Health Est. completion 2009-10 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2007-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Jonsson Comprehensive Cancer Center 58 participants Est. completion 2009-03 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00050011
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Not yet reported Novartis Pharmaceuticals 602 participants Est. completion 2009-01 44 sitesOther conditions: Breast Neoplasms, OsteoporosisView official trial listing → -
Completed NCT NCT00055731
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Not yet reported UNICANCER 413 participants Est. completion 2022-12-31 38 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00063310
ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
Not yet reported Voyager Pharmaceutical Corporation 90 participants Est. completion 2006-02 3 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00065767
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2005-03 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Terminated NCT NCT00066807
Premenopausal Endocrine Responsive Chemotherapy Trial
Not yet reported ETOP IBCSG Partners Foundation 29 participants Est. completion 2006-12 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00067015
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00072020
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
Not yet reported University of SheffieldOther conditions: Breast Cancer, Metastatic CancerView official trial listing → -
Status unknown NCT NCT00077168
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
Not yet reported Institute of Cancer Research, United Kingdom 2000 participants 29 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00078585
PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
Not yet reported Bavarian Nordic 120 participants Est. completion 2009-01 47 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00083993
Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1236 participants Est. completion 2006-10 129 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT00085293
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2014-05 3 sitesOther conditions: Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid CancerView official trial listing → -
Terminated NCT NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-DependentView official trial listing → -
Active, not recruiting NCT NCT00099437
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Not yet reported AstraZeneca 736 participants Est. completion 2026-12-31 106 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00102258
Role of Nutrition and Hormones in Boys With Disordered Growth
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 20 participants Est. completion 2007-10-02 1 siteOther conditions: Short Stature, Constitutional Delay of Growth and Development, Dwarfism, PituitaryView official trial listing → -
Terminated NCT NCT00103376
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
Not yet reported Medical University of South Carolina 23 participants Est. completion 2011-06 4 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00104715
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
Not yet reported UNICANCER 385 participants Est. completion 2015-12-15 41 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00108290
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
Not yet reported US Department of Veterans Affairs Est. completion 2007-03 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00109473
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2009-08 1 siteOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT00110214
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported National Cancer Institute (NCI) 1050 participants Est. completion 2011-08 2 sitesOther conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT00116220
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
Not yet reported Dana-Farber Cancer Institute 206 participants Est. completion 2015-02 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00117663
Radiologic Evaluation and Breast Density (READ)
Not yet reported Kaiser Permanente 1704 participants Est. completion 2007-11 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00120497
Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
Massachusetts General Hospital 12 participants Est. completion 2011-12 1 siteOther conditions: Fetal Growth RetardationView official trial listing → -
Terminated NCT NCT00121875
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
Massachusetts General Hospital 1 participants Est. completion 2008-12 1 siteOther conditions: Turner Syndrome, Idiopathic Short StatureView official trial listing → -
Completed NCT NCT00124410
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation
AHS Cancer Control Alberta 100 participants 1 siteOther conditions: Prostate Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00128843
Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
Not yet reported Spanish Breast Cancer Research Group 103 participants Est. completion 2014-10 13 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00128934
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 744 participants Est. completion 2007-12 83 sitesOther conditions: Menstruation Disturbances, Premenstrual SyndromeView official trial listing → -
Terminated NCT NCT00131924
High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00134056
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Not yet reported SWOG Cancer Research Network 1038 participants Est. completion 2016-02 554 sitesOther conditions: Metastatic Cancer, Prostate CancerView official trial listing → -
Completed NCT NCT00134420
Growth Hormone and Chromosome 18q- and Abnormal Growth
Not yet reported The University of Texas Health Science Center at San Antonio 20 participants Est. completion 2005-06 1 siteOther conditions: Loss of Chromosome 18q, Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT00138008
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
Not yet reported Haruhiko Fukuda 200 participants Est. completion 2016-05 34 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00141544
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00141570
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 350 participants Est. completion 2007-06 77 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00148772
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Not yet reported Endeavor Health 29 participants Est. completion 2008-08 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00149604
AFTER: Altering Fat Through Estrogen and Raloxifene
Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sitesOther conditions: Adenocarcinoma of the Prostate, Prostate CancerView official trial listing → -
Completed NCT NCT00166543
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
Not yet reported SRI International 146 participants Est. completion 2008-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00172055
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Not yet reported Novartis Pharmaceuticals 218 participants Est. completion 2009-07 19 sitesOther conditions: Cancer ProstateView official trial listing → -
Completed NCT NCT00172224
Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research
National Taiwan University Hospital 100 participants 1 siteOther conditions: Osteoporosis, Fractures, CompressionView official trial listing → -
Completed NCT NCT00174408
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Not yet reported Pfizer 110 participants Est. completion 2005-02Other conditions: Growth DisordersView official trial listing → -
Completed NCT NCT00175383
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
Not yet reported University of British Columbia 100 participants Est. completion 2008-02 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00176631
Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported Rutgers, The State University of New Jersey 10 participants Est. completion 2008-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00182871
Testosterone Effects on Bone and Frailty
Not yet reported National Institute on Aging (NIA) 140 participants Est. completion 2007-07 1 siteOther conditions: Aging, Frailty, OsteoporosisView official trial listing → -
Completed NCT NCT00183040
HORMA: Hormonal Regulators of Muscle and Metabolism in Aging
Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2007-02 2 sitesOther conditions: Sarcopenia, Muscle Weakness, FrailtyView official trial listing → -
Completed NCT NCT00184691
Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years
Not yet reported Novo Nordisk A/S 78 participants Est. completion 2005-06 13 sitesOther conditions: Foetal Growth Problem, Small for Gestational AgeView official trial listing → -
Completed NCT NCT00184769
Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
Not yet reported Novo Nordisk A/S 16 participants Est. completion 2005-12-21 20 sitesChronic kidney disease Other conditions: Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT00188760
Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density
University Health Network, Toronto 300 participants Est. completion 2010-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00191529
Growth Hormone Treatment in Short Children Born Small for Gestational Age
Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-06 1 siteOther conditions: Infant, Small for Gestational AgeView official trial listing → -
Completed NCT NCT00193856
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Not yet reported Trans Tasman Radiation Oncology Group 1071 participants Est. completion 2017-08 24 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00194792
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
Not yet reported University of Washington 28 participants Est. completion 2011-07 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast CancerView official trial listing → -
Completed NCT NCT00195559
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sitesOther conditions: Premenstrual Syndrome, Menstruation DisturbancesView official trial listing → -
Terminated NCT NCT00206375
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Not yet reported Baylor College of Medicine 16 participants Est. completion 2011-11 1 siteOther conditions: HypothyroidismView official trial listing → -
Completed NCT NCT00206557
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
Not yet reported The Alfred 60 participants Est. completion 2007-04 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Terminated NCT NCT00209001
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Not yet reported Emory University 7 participants Est. completion 2007-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00210223
Radiofrequency of Breast Cancers in Non Surgical Patients
Not yet reported Institut Bergonié 21 participants Est. completion 2011-12 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00216060
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
Not yet reported Christopher Sweeney, MBBS 63 participants Est. completion 2008-03 45 sitesOther conditions: Metastatic Prostate CancerView official trial listing → -
Completed NCT NCT00223665
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
Not yet reported University of Washington 102 participants Est. completion 2012-09-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00225420
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 23 participants Est. completion 2012-08 2 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00225758
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Not yet reported Gary Schwartz 27 participants Est. completion 2011-10 3 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00225914
Study of Paxil Use in Menopausal Women
Not yet reported Massachusetts General Hospital 64 participants Est. completion 2006-09 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00231946
ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Not yet reported Voyager Pharmaceutical Corporation 555 participants 59 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Terminated NCT NCT00236301
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 siteOther conditions: Healthy Symptomatic Menopausal WomenView official trial listing → -
Completed NCT NCT00237198
Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
Not yet reported Novartis Pharmaceuticals 47 participants 24 sitesOther conditions: Postmenopausal Women With Advanced Breast CancerView official trial listing → -
Completed NCT NCT00240071
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT00242931
Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy
Not yet reported OHSU Knight Cancer Institute Est. completion 2008-03Other conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00243646
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
Not yet reported Schiffler Cancer Center 6 participants Est. completion 2009-07 3 sitesOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT00244920
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Not yet reported OHSU Knight Cancer Institute Est. completion 2007-06Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00246753
Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported UNC Lineberger Comprehensive Cancer Center 29 participants Est. completion 2013-05 3 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00247650
Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy
Not yet reported Novartis 190 participants 10 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00249821
Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age
Not yet reported Merck KGaA, Darmstadt, Germany 22 participants Est. completion 2007-09-30Other conditions: Small Gestational Age (SGA)View official trial listing → -
Withdrawn NCT NCT00256555
Growth Hormone Treatment Study in Children With Cystic Fibrosis
Not yet reported, Not yet reported University of Texas Southwestern Medical Center Est. completion 2018-12-12Other conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00258388
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Not yet reported NCIC Clinical Trials Group 82 participants Est. completion 2011-01-18 13 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00267553
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 200 participants Est. completion 2006-06 35 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-DependentView official trial listing → -
Completed NCT NCT00288080
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 612 participants Est. completion 2022-05-20 254 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00291759
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
Not yet reported AstraZeneca 3858 participants Est. completion 2009-06 52 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00295620
Secondary Adjuvant Long Term Study With Arimidex
Not yet reported AstraZeneca 3484 participants Est. completion 2017-06-30 60 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00304096
Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
Not yet reported University of Virginia 12 participants Est. completion 2008-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00305448
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00305747
Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
Not yet reported Barbara Ann Karmanos Cancer Institute 12 participants Est. completion 2010-09 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00309894
Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Not yet reported University of California, San Francisco 49 participants Est. completion 2007-12 2 sitesOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT00310180
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Not yet reported National Cancer Institute (NCI) 10273 participants Est. completion 2030-09-30 1222 sites Stand-aloneOther conditions: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7View official trial listing → -
Completed NCT NCT00313170
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
Not yet reported AstraZeneca 144 participants Est. completion 2019-03-13 34 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00319072
Hormone Replacement Therapy (HRT) Website Tool
Not yet reported National Institute on Aging (NIA) 280 participants Est. completion 2005-12 1 siteOther conditions: Communication, Menopause, Hormone Replacement TherapyView official trial listing → -
Completed NCT NCT00328614
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 32 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00330317
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Not yet reported Novartis Pharmaceuticals 300 participants Est. completion 2010-11-16 20 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00334295
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sitesOther conditions: Endometrial CarcinomaView official trial listing → -
Completed NCT NCT00343616
Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98
Not yet reported ETOP IBCSG Partners Foundation 135 participants Est. completion 2009-05 12 sitesOther conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Status unknown NCT NCT00348998
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Not yet reported Virginia Mason Hospital/Medical Center 18 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00351858
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Not yet reported Neovii Biotech 40 participants Est. completion 2009-02 1 siteOther conditions: Breast Neoplasms, Breast CancerView official trial listing → -
Terminated NCT NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Not yet reported Wake Forest University Health Sciences 120 participants Est. completion 2010-08-01 20 sitesOther conditions: Hot Flashes, Prostate CancerView official trial listing → -
Completed NCT NCT00355784
Growth Hormone as a Determinant of Weight Regulation
Not yet reported University of Michigan 24 participants Est. completion 2015-12 1 siteOther conditions: ObesityView official trial listing → -
Terminated NCT NCT00358098
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
AHS Cancer Control Alberta 51 participants Est. completion 2013-06 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00362973
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
University of Washington 42 participants 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00363285
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Not yet reported St. Bartholomew's Hospital 900 participants 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00373386
Growth Hormone and Endothelial Function in Children
Not yet reported Ohio State University 9 participants Est. completion 2007-12 1 siteOther conditions: Growth Hormone Deficiency, Panhypopituitarism, Short StatureView official trial listing → -
Terminated NCT NCT00375752
Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
Not yet reported Novartis Pharmaceuticals 168 participants Est. completion 2010-12-16 27 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT00379626
Cognitive and Hormonal Treatment of Sex Offenders
Not yet reported Norwegian University of Science and Technology 5 participants Est. completion 2010-08 1 siteOther conditions: ParaphiliaView official trial listing → -
Completed NCT NCT00384839
Vidaza to Restore Hormone Thx Prostate
Not yet reported US Oncology Research 36 participants Est. completion 2009-11 13 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00388804
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 39 participants Est. completion 2011-04 1 siteOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT00396474
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
Pfizer Est. completion 2012-01Other conditions: Infant, Small for Gestational AgeView official trial listing → -
Withdrawn NCT NCT00403182
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
Not yet reported Technical University of Munich 9 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00405574
Study of ATN-224 in Patients With Prostate Cancer
Not yet reported Attenuon 50 participants Est. completion 2008-09 6 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00407251
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
Not yet reported British Columbia Cancer Agency 73 participants 5 sitesOther conditions: Hormone Refractory Prostate CancerView official trial listing → -
Status unknown NCT NCT00411853
Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Not yet reported Sheba Medical Center 60 participants Est. completion 2012-06 1 siteOther conditions: Hormone Refractory Prostate CancerView official trial listing → -
Completed NCT NCT00420251
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
Not yet reported Ludwig-Maximilians - University of Munich 50 participants Est. completion 2006-07 1 siteOther conditions: Juvenile Idiopathic Arthritis, Still Disease, Juvenile-OnsetView official trial listing → -
Completed NCT NCT00420654
Growth Hormone Treatment of Women With Turner Syndrome
Not yet reported Britta E. Hjerrild 24 participants Est. completion 2011-09 1 siteOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT00433446
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported SWOG Cancer Research Network 62 participants Est. completion 2011-07 123 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00433589
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 6600 participants Est. completion 2020-03 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00437359
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
Not yet reported Japan Breast Cancer Research Network 240 participants Est. completion 2020-05 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00450463
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
Not yet reported National Cancer Institute (NCI) 64 participants Est. completion 2017-06-08 3 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00452140
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
Not yet reported Neovii Biotech 40 participants Est. completion 2009-02 5 sitesOther conditions: Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT00452556
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
Not yet reported Nova Scotia Cancer Centre 86 participants Est. completion 2017-02 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00458263
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Not yet reported Rabin Medical Center 21 participants Est. completion 2011-05 1 siteOther conditions: Idiopathic Short StatureView official trial listing → -
Completed NCT NCT00458991
rhGH Therapy on Hepatic Drug Metabolism
University of Louisville 9 participants Est. completion 2008-09 4 sitesOther conditions: Growth Hormone Deficiency, DwarfismView official trial listing → -
Completed NCT NCT00460031
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2010-08-31 6 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00464516
Preoperative Estetrol in Breast Cancer
Not yet reported Pantarhei Bioscience 30 participants Est. completion 2010-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00466102
Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases
Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2012-12 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00471718
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 27 participants Est. completion 2009-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00473187
Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
Not yet reported University of Rostock Est. completion 2009-08 1 siteOther conditions: Hypophosphatemic Rickets, Growth Disorders, Somatropin TherapyView official trial listing → -
Completed NCT NCT00482391
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 95 participants Est. completion 2011-07 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00483561
Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported University of Nebraska 26 participants Est. completion 2010-01 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00486642
Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported National Cancer Institute (NCI) 23 participants Est. completion 2015-09 6 sitesOther conditions: Hormone-Resistant Prostate Cancer, Recurrent Prostate CarcinomaView official trial listing → -
Completed NCT NCT00499083
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00512668
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
Not yet reported National Cancer Institute (NCI) 24 participants 1 site Stand-aloneOther conditions: Adenocarcinoma of the Prostate, Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT00513071
AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported National Cancer Institute (NCI) 28 participants Est. completion 2008-10 1 siteOther conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT00519844
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
Not yet reported Novo Nordisk A/S 5 participants Est. completion 2006-01 1 siteOther conditions: Foetal Growth Problem, Small for Gestational AgeView official trial listing → -
Terminated NCT NCT00521781
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
Not yet reported The Methodist Hospital Research Institute 14 participants Est. completion 2008-10 1 site Stand-aloneOther conditions: Prostatic NeoplasmsView official trial listing → -
Terminated NCT NCT00525161
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Not yet reported Suleiman Massarweh 11 participants Est. completion 2015-01 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00527124
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2013-11 4 sitesOther conditions: Adenocarcinoma of the Prostate, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT00530868
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
Not yet reported University of Alabama at Birmingham 75 participants Est. completion 2022-03-31 7 sitesOther conditions: Breast Cancer, Cancer of the Breast, Breast NeoplasmView official trial listing → -
Completed NCT NCT00535418
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
Not yet reported, Not yet reported Novartis Pharmaceuticals 35 participantsOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00537771
Liver Safety Under Upfront Arimidex vs Tamoxifen
Not yet reported AstraZeneca 384 participants Est. completion 2011-12 16 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00544167
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
Not yet reported SCRI Development Innovations, LLC 45 participants Est. completion 2011-04 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT00544830
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Not yet reported City of Hope Medical Center 29 participants Est. completion 2027-02-15 2 sitesOther conditions: PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7View official trial listing → -
Status unknown NCT NCT00547001
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
Not yet reported Hartford Hospital 235 participants Est. completion 2009-11 1 siteOther conditions: Hot Flashes, Night SweatsView official trial listing → -
Completed NCT NCT00553410
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 4884 participants Est. completion 2019-05-15 164 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00554918
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy
Not yet reported University Hospital Birmingham 300 participants Est. completion 2013-06 16 sitesOther conditions: Metastatic Cancer, Prostate CancerView official trial listing → -
Completed NCT NCT00555919
ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer
Not yet reported Bayer 68 participants Est. completion 2011-03 28 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00557336
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
Not yet reported Novo Nordisk A/S 160 participants Est. completion 2005-06-29 37 sitesOther conditions: Foetal Growth Problem, Small for Gestational AgeView official trial listing → -
Status unknown NCT NCT00561444
Quality of Life Study for Prostate Cancer Patients
M.D. Anderson Cancer Center 1051 participants Est. completion 2020-11 3 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00570258
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT00579072
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older
Memorial Sloan Kettering Cancer Center 230 participants Est. completion 2027-12 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00588003
Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 45 participants Est. completion 2009-11 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00589420
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Not yet reported Abramson Cancer Center at Penn Medicine 18 participants Est. completion 2011-02-02 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00601900
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
Not yet reported National Cancer Institute (NCI) 394 participants Est. completion 2024-01-29 522 sitesOther conditions: Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT00602043
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2014-09 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT00604318
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
Not yet reported Copenhagen University Hospital at Herlev 56 participants Est. completion 2012-02 1 siteOther conditions: Thyroid CancerView official trial listing → -
Completed NCT NCT00604825
Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sitesOther conditions: Menopausal and Female Climacteric StatesView official trial listing → -
Completed NCT NCT00617942
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
Not yet reported William Sikov MD 60 participants Est. completion 2015-12 5 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00626106
QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Not yet reported NantCell, Inc. 156 participants Est. completion 2011-09-23 60 sitesOther conditions: Breast Cancer, Breast Tumors, Metastatic CancerView official trial listing → -
Completed NCT NCT00627354
Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported Groupe D'Etude des Tumeurs Uro-Genitales 90 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00647218
Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 38 participants Est. completion 2004-11 6 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00651222
Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy
Prostate Cancer Foundation of Chicago 1 siteOther conditions: Prostate Cancer, Cardiovascular DeathView official trial listing → -
Terminated NCT NCT00661531
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sitesOther conditions: Breast Cancer, Cancer of the Breast, Neoplasms, BreastView official trial listing → -
Terminated NCT NCT00665457
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Not yet reported University of Nebraska 3 participants Est. completion 2009-07-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00666822
Compliance to a Hormone Therapy Regimen in Breast Cancer
Case Comprehensive Cancer Center 178 participants Est. completion 2015-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00667069
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
Not yet reported UNICANCER 424 participants Est. completion 2022-05-24 17 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00668083
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer
AstraZeneca 214 participants Est. completion 2008-07 12 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00668603
Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Not yet reported University of Helsinki 160 participants Est. completion 2008-03 1 siteCardiovascular disease Other conditions: Postmenopausal Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00669162
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
Not yet reported, Not yet reported University of Kansas Medical Center 27 participants Est. completion 2017-04 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00681122
CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)
AstraZeneca 2600 participants Est. completion 2011-05 164 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00685009
The Women's Health Initiative Memory Study (The WHIMS Study)
National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 siteOther conditions: Dementia SyndromesView official trial listing → -
Terminated NCT NCT00686036
Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy
Not yet reported Genzyme, a Sanofi Company 17 participants Est. completion 2010-10 11 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00687739
Prevention of Obesity in Women Via Estradiol Regulation
Not yet reported University of Colorado, Denver 79 participants Est. completion 2014-06 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00711061
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
Children's Mercy Hospital Kansas City 24 participants Est. completion 2009-02 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT00713440
Incretin Physiology Associated With Steroid Hormone Treatment
Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2009-01 1 siteType 2 diabetes Other conditions: SteroidsView official trial listing → -
Completed NCT NCT00726661
An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)
Genentech, Inc. 1287 participants Est. completion 2012-12Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00738205
Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector
Merck KGaA, Darmstadt, Germany 834 participants Est. completion 2009-06Other conditions: Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Failure, Small for Gestational AgeView official trial listing → -
Terminated NCT NCT00743327
Androgen Deprivation Therapy Study
National Institute on Aging (NIA) 1 participants Est. completion 2012-08 1 siteMetabolic syndrome Other conditions: Hypogonadism, Diabetes, InflammationView official trial listing → -
Completed NCT NCT00745056
Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study)
Wake Forest University Health Sciences 2922 participants Est. completion 2021-11-04 1 siteOther conditions: DementiaView official trial listing → -
Terminated NCT NCT00748969
Clinical Trial of Growth Hormone in MPS I, II, and VI
Not yet reported, Not yet reported Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 2 participants Est. completion 2013-09 1 siteOther conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VIView official trial listing → -
Completed NCT NCT00757393
Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis
Not yet reported The Hospital for Sick Children 21 participants Est. completion 2015-09 1 siteOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT00764166
A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel
Not yet reported Assistance Publique - Hôpitaux de Paris 254 participants Est. completion 2010-11 1 siteOther conditions: Adenocarcinoma of the ProstateView official trial listing → -
Completed NCT NCT00769548
Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 1322 participants Est. completion 2016-12Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00773695
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00781547
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
Not yet reported Göteborg University 40 participants Est. completion 2005-05 1 siteMetabolic syndrome Other conditions: Abdominal Obesity, ObesityView official trial listing → -
Completed NCT NCT00784888
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
Pfizer 344 participants Est. completion 2011-12 16 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT00796458
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
Not yet reported A.O.U. San Giovanni Battista di Torino, Italy 200 participants 1 siteOther conditions: Pain, Prostate CancerView official trial listing → -
Completed NCT NCT00808041
Chemotherapy Monitoring With Breast Computed Tomography (CT)
Emory University 3 participants Est. completion 2015-07 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00813189
Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid
Not yet reported Association REMEDE 30 participants Est. completion 2012-05 1 siteOther conditions: Chronic Disease, Glucocorticoid Therapy, Response to, Growth RetardationView official trial listing → -
Completed NCT NCT00817739
Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c
Not yet reported Takeda 341 participants Est. completion 2008-12Other conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00833248
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Not yet reported Ferring Pharmaceuticals 246 participants Est. completion 2011-09 66 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12Other conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, SarcomasView official trial listing → -
Completed NCT NCT00849758
Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients
Universitaire Ziekenhuizen KU Leuven 110 participants Est. completion 2014-09 2 sitesOther conditions: Breast Cancer, ElderlyView official trial listing → -
Status unknown NCT NCT00867971
Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?
Assaf-Harofeh Medical Center 100 participants Est. completion 2010-10 1 siteOther conditions: Growth Hormone Treatment, GlaucomaView official trial listing → -
Status unknown NCT NCT00868868
Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy
Groupe de recherche en Urologie de la Mauricie 400 participants Est. completion 2011-09 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00878436
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Not yet reported, Not yet reported NYU Langone Health 52 participants Est. completion 2015-07 4 sitesOther conditions: Prostate Cancer, Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00884143
Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer
AstraZeneca 515 participants Est. completion 2010-01 3 sitesOther conditions: Post Menopausal, Breast CancerView official trial listing → -
Status unknown NCT NCT00887380
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)
Not yet reported Trans Tasman Radiation Oncology Group 2023 participants Est. completion 2024-12 34 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00893061
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
Not yet reported Centre Oscar Lambret 44 participants Est. completion 2014-11-26 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00895310
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Not yet reported University of California, Davis 30 participants Est. completion 2015-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00895466
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Not yet reported, Not yet reported Pepscan Therapeutics 12 participants 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00897962
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
University of California, Davis 163 participants Est. completion 2016-01-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00898326
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 198 participants Est. completion 2016-12-31 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00899288
Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98
Not yet reported ETOP IBCSG Partners Foundation 60 participants Est. completion 2007-07Other conditions: Breast Cancer, OsteoporosisView official trial listing → -
Active, not recruiting NCT NCT00903591
Study of Radiation Exposure and Bilateral Breast Cancer
Memorial Sloan Kettering Cancer Center 1699 participants Est. completion 2027-05 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00912340
Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer
Not yet reported Emory University 70 participants Est. completion 2017-07 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00921115
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 siteOther conditions: Invasive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT00929214
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2027-12-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00929591
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
Not yet reported SWOG Cancer Research Network 1558 participants Est. completion 2010-03Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00932152
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 siteOther conditions: Non-small Cell Lung Cancer, Postmenopausal WomenView official trial listing → -
Completed NCT NCT00943527
Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
Mayo Clinic 110 participants Est. completion 2012-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00955435
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
Cancer Trials Ireland 60 participants Est. completion 2026-08-06 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00963729
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
Not yet reported Imperial College London 756 participants Est. completion 2011-03 5 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT00967863
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
Not yet reported UNICANCER 500 participants Est. completion 2026-10 25 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00990886
The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women
Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 148 participants Est. completion 2005-01Other conditions: Menopause, Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT00999804
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Not yet reported Baylor Breast Care Center 128 participants Est. completion 2026-01 8 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01006564
Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer
Not yet reported Royal Marsden NHS Foundation Trust 30 participants Est. completion 2011-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT01013506
Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2009-12Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT01016665
Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
Not yet reported Federal University of São Paulo 71 participants Est. completion 2008-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01023061
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
Not yet reported University of Washington 24 participants Est. completion 2015-09 2 sitesOther conditions: Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT01023802
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
Mayo Clinic 20 participants Est. completion 2011-02 1 siteOther conditions: Neoadjuvant Therapy, Chemotherapy, Hormone Replacement Therapy, Breast CancerView official trial listing → -
Completed NCT NCT01025349
Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer
Not yet reported Taipei Medical University Hospital 20 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01046643
Early Menopause Hormone Treatment and Cognition
Not yet reported University of Michigan 30 participants Est. completion 2012-03 1 siteOther conditions: Menopausal SyndromeView official trial listing → -
Completed NCT NCT01065220
Sex Steroids and the Serotonin Transporter
Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 siteOther conditions: TranssexualismView official trial listing → -
Completed NCT NCT01066052
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
Not yet reported Merck KGaA, Darmstadt, Germany 115 participants Est. completion 2010-08-31 1 siteOther conditions: Turner's SyndromeView official trial listing → -
Completed NCT NCT01070485
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
Not yet reported Bayer 23 participants Est. completion 2012-01 4 sitesOther conditions: Breast Cancer, Bone MetastasesView official trial listing → -
Status unknown NCT NCT01072318
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
Not yet reported Korean Breast Cancer Study Group 495 participants Est. completion 2014-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01076335
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01081613
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
University Medical Center Groningen 7 participants Est. completion 2012-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01122121
Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer
Not yet reported Takeda 273 participants Est. completion 2009-06 1 siteOther conditions: Prostatic Neoplasms, Locally AdvancedView official trial listing → -
Completed NCT NCT01124773
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
Wake Forest University Health Sciences 1362 participants Est. completion 2016-06 1 siteOther conditions: DementiaView official trial listing → -
Completed NCT NCT01129336
Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
Not yet reported Novartis Pharmaceuticals 44 participants Est. completion 2012-08 33 sites Stand-aloneOther conditions: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone MetastasisView official trial listing → -
Completed NCT NCT01138345
Biomarkers in Blood Samples From Older Breast Cancer Survivors
UNC Lineberger Comprehensive Cancer Center 246 participants Est. completion 2014-02 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01151215
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Not yet reported AstraZeneca 482 participants Est. completion 2013-01 60 sitesOther conditions: Neoplasms, Breast Neoplasms, Breast CancerView official trial listing → -
Completed NCT NCT01176916
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
Not yet reported Pfizer 564 participants Est. completion 2018-11-30 53 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01194271
Neoadjuvant Ipilimumab in Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 19 participants Est. completion 2015-10 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01202591
Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients
Not yet reported, Not yet reported AstraZeneca 127 participants Est. completion 2014-10 21 sitesOther conditions: FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast CancerView official trial listing → -
Terminated NCT NCT01205685
Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 11 participants Est. completion 2011-07 3 sitesOther conditions: Hormone-sensitive Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01239251
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
Memorial Sloan Kettering Cancer Center 8 participants Est. completion 2011-11 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT01240928
MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer CenterOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT01240941
Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2012-12Other conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01246427
Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer
Not yet reported Centre Leon Berard 138 participants Est. completion 2014-11 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01248494
PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 72 participants Est. completion 2016-05 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01250717
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2011-05 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01259778
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea
Merck KGaA, Darmstadt, Germany 224 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01263457
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
Merck KGaA, Darmstadt, Germany 191 participants Est. completion 2015-12-31 6 sitesOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01263717
Effects of Growth Hormone Releasing Hormone in HIV
Not yet reported Massachusetts General Hospital 54 participants Est. completion 2014-02 1 siteOther conditions: HIV, HIV LipodystrophyView official trial listing → -
Completed NCT NCT01265654
Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
AstraZeneca 234 participants Est. completion 2011-11 37 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01267526
A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment
Merck KGaA, Darmstadt, Germany 205 participants Est. completion 2015-12-31 9 sitesOther conditions: Growth DisordersView official trial listing → -
Active, not recruiting NCT NCT01272037
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Not yet reported National Cancer Institute (NCI) 5018 participants Est. completion 2027-01-08 1568 sitesOther conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Synchronous Bilateral Breast CarcinomaView official trial listing → -
Completed NCT NCT01281137
Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01291394
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
Merck KGaA, Darmstadt, Germany 223 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01292785
Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity
Medical University of Vienna 80 participants Est. completion 2015-04 1 siteOther conditions: Gender Identity DisorderView official trial listing → -
Completed NCT NCT01293032
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sites Stand-aloneOther conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast CancerView official trial listing → -
Terminated NCT NCT01296555
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sitesOther conditions: Solid Cancers, Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT01300351
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women
Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01302041
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Not yet reported Astellas Pharma Inc 67 participants Est. completion 2017-04-27 12 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01302652
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Massachusetts General Hospital 20 participants Est. completion 2015-02 1 siteOther conditions: AcromegalyView official trial listing → -
Completed NCT NCT01307059
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden
Merck KGaA, Darmstadt, Germany 152 participants Est. completion 2015-12-31 3 sitesOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01309555
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia
Merck KGaA, Darmstadt, Germany 33 participants Est. completion 2016-10-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01309672
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2024-04-11 205 sitesOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT01320046
Vulvar Contact Dermatitis Resulting From Urine Incontinence
Meir Medical Center Est. completion 2012-03 1 siteOther conditions: Urinary Incontinence, Vulvar Pruritus, Vulvar Contact DermatitisView official trial listing → -
Active, not recruiting NCT NCT01327781
Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sitesOther conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT01329757
Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury
Not yet reported Hospital Nacional de Parapléjicos de Toledo 76 participants Est. completion 2015-11 1 siteOther conditions: Spinal Cord InjuryView official trial listing → -
Completed NCT NCT01344564
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
Not yet reported Urology of Virginia 50 participants Est. completion 2012-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT01350180
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
Dr. Tamim Niazi Est. completion 2022-12-01 8 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT01351844
The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
Not yet reported George Washington University 12 participants Est. completion 2013-05 1 siteOther conditions: Breast Cancer, ArthralgiaView official trial listing → -
Status unknown NCT NCT01352091
Adjuvant AI Combined With Zoladex
Not yet reported Fudan University 670 participants Est. completion 2018-04 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01368263
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Not yet reported Washington University School of Medicine 8 participants Est. completion 2013-05 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Terminated NCT NCT01374087
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Not yet reported Ipsen 32 participants Est. completion 2014-12 11 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01376921
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain
Merck KGaA, Darmstadt, Germany 300 participants Est. completion 2015-03-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01384526
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
University of California, San Francisco 266 participants Est. completion 2015-03 1 siteOther conditions: Breast Cancer, FertilityView official trial listing → -
Completed NCT NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Terminated NCT NCT01392586
Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer
Not yet reported Jeroen Bosch Ziekenhuis 10 participants Est. completion 2014-01 26 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01397500
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
Not yet reported Max-Planck-Institute of Psychiatry 54 participants Est. completion 2015-03 1 siteOther conditions: Hormone DeficiencyView official trial listing → -
Completed NCT NCT01400984
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
Merck KGaA, Darmstadt, Germany 92 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01400997
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
Merck KGaA, Darmstadt, Germany 206 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01402999
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
Merck KGaA, Darmstadt, Germany 83 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01419197
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Not yet reported Hoffmann-La Roche 602 participants Est. completion 2015-08 184 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01419249
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Not yet reported Merck KGaA, Darmstadt, Germany 458 participants Est. completion 2012-10 31 sitesOther conditions: Idiopathic Growth Hormone Deficiency, Turner SyndromeView official trial listing → -
Completed NCT NCT01420250
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20 participants Est. completion 2020-07-21 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01421589
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
Not yet reported Massachusetts General Hospital 15 participants Est. completion 2013-03 1 siteOther conditions: Obese, Growth Hormone Secretion AbnormalityView official trial listing → -
Completed NCT NCT01422408
Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
Not yet reported OHSU Knight Cancer Institute 34 participants Est. completion 2015-10 1 siteOther conditions: Breast CarcinomaView official trial listing → -
Completed NCT NCT01423890
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
Not yet reported Ontario Clinical Oncology Group (OCOG) 1011 participants Est. completion 2014-02 35 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01431391
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Not yet reported Dendreon 68 participants Est. completion 2014-12 14 sitesOther conditions: Prostatic Neoplasm, Prostate Cancer, Prostatic AdenocarcinomaView official trial listing → -
Completed NCT NCT01432028
Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Not yet reported Denusa Wiltgen 90 participants Est. completion 2011-04 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT01438528
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment
Merck KGaA, Darmstadt, Germany 75 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01439061
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
Merck KGaA, Darmstadt, Germany 220 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01441713
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Copenhagen University Hospital at Herlev 178 participants Est. completion 2012-06 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT01444820
Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate
Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 329 participants Est. completion 2026-01 12 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01446159
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Not yet reported MedImmune LLC 188 participants Est. completion 2019-06-28 71 sitesOther conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01471288
Effect of Carum Carvi on Thyroid Hormones and TSH Level
Not yet reported, Not yet reported Mashhad University of Medical Sciences 40 participants 1 siteOther conditions: Thyroid Cancer PatientsView official trial listing → -
Terminated NCT NCT01477060
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Not yet reported Fondazione Michelangelo 32 participants Est. completion 2013-12 11 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01481090
Electro-acupuncture and Assisted Reproductive Technology
Not yet reported National University of Health Sciences 16 participants Est. completion 2012-03 2 sitesOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01491854
Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age
Not yet reported Sandoz 130 participants Est. completion 2018-10-31 23 sitesOther conditions: Short Children Born Small for Gestational Age (SGA)View official trial listing → -
Completed NCT NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
Not yet reported University of Chicago 9 participants Est. completion 2018-05 2 sitesOther conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01500486
Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™
Novo Nordisk A/S 84 participants Est. completion 2009-03 4 sitesOther conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Delivery SystemsView official trial listing → -
Status unknown NCT NCT01503905
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2021-12 17 sitesOther conditions: Breast Cancer Nos PremenopausalView official trial listing → -
Terminated NCT NCT01528345
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Not yet reported Novartis Pharmaceuticals 97 participants Est. completion 2015-04 67 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01531205
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 2 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01546623
A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy
Not yet reported Takeda 160 participants Est. completion 2014-04 16 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01548677
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1317 participants Est. completion 2017-03 80 sitesOther conditions: Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Circulating Tumor CellsView official trial listing → -
Withdrawn NCT NCT01549288
Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy
Not yet reported, Not yet reported Lady Hardinge Medical College Est. completion 2013-12 1 siteOther conditions: Infantile SpasmsView official trial listing → -
Completed NCT NCT01553903
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
Not yet reported Institut Claudius Regaud 29 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01555528
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico
Merck KGaA, Darmstadt, Germany 193 participants Est. completion 2015-12-31 1 siteOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT01556243
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 270 participants Est. completion 2023-04-15 350 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01580605
French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
Novo Nordisk A/S 331 participants Est. completion 2011-11-28 1 siteOther conditions: Growth Hormone Disorder, Adult Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT01602380
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sitesOther conditions: Hormone Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01605071
Timing Estrogen After MenoPaUSe
Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 siteOther conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT01612871
Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
Not yet reported Institut Claudius Regaud 39 participants Est. completion 2016-01-28 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01613131
Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression
Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-06 1 siteOther conditions: Menopausal and Other Perimenopausal DisordersView official trial listing → -
Withdrawn NCT NCT01614171
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Not yet reported University of Maryland, Baltimore Est. completion 2015-12 1 siteOther conditions: Osteoporosis Pseudoglioma SyndromeView official trial listing → -
Completed NCT NCT01614210
Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
Not yet reported University of Utah 52 participants Est. completion 2016-11 1 siteOther conditions: Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerView official trial listing → -
Completed NCT NCT01615120
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Not yet reported GTx 77 participants Est. completion 2016-11-09 26 sitesOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT01616758
Phase II Study of GTx024 in Women With Metastatic Breast Cancer
Not yet reported GTx 22 participants Est. completion 2016-03 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01619111
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs
Not yet reported Prof. Wolfgang Janni 105 participants Est. completion 2022-01 1 siteOther conditions: HER2-negative Metastatic Breast Cancer, HER2-positive Circulating Tumor CellsView official trial listing → -
Status unknown NCT NCT01622361
Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01630590
Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2021-04-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1458 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01694225
Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
Not yet reported University of Louisville 87 participants Est. completion 2018-01-28 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01697644
Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
Not yet reported Novo Nordisk A/S 75 participants Est. completion 2005-05 2 sitesOther conditions: Foetal Growth Problem, Small for Gestational AgeView official trial listing → -
Terminated NCT NCT01698944
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
Not yet reported Novo Nordisk A/S 7 participants Est. completion 2002-11-18 1 siteOther conditions: Growth Hormone Disorder, Adult Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT01712230
Females, Aging, Metabolism, and Exercise
Not yet reported University of Colorado, Denver 47 participants Est. completion 2017-10 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01720602
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Not yet reported University of Washington 15 participants Est. completion 2020-01 1 siteOther conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01722851
Circulating miRNAs.
Cancer Trials Ireland 255 participants Est. completion 2021-12 7 sitesOther conditions: Breast Cancer, Newly Diagnosed Breast Cancer, Recurrent Breast CancerView official trial listing → -
Completed NCT NCT01729676
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation
Ferring Pharmaceuticals 315 participants Est. completion 2014-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01736163
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
Genzyme, a Sanofi Company 144 participants Est. completion 2012-08 9 sitesOther conditions: Thyroid CancerView official trial listing → -
Withdrawn NCT NCT01738685
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy
Not yet reported University of Pittsburgh Est. completion 2015-12 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT01741883
Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients
Not yet reported Philipps University Marburg 165 participants Est. completion 2020-08 1 siteOther conditions: Female Breast CancerView official trial listing → -
Completed NCT NCT01745965
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.
Not yet reported Women's Cancer Study Group GmbH 380 participants Est. completion 2025-01-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01750398
Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2015-06 1 siteOther conditions: Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT01753297
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
Not yet reported Ipsen 226 participants Est. completion 2019-09-09 18 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT01758146
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 412 participants Est. completion 2020-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01765049
Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor
Seoul National University Hospital 260 participants Est. completion 2025-12-15 1 siteOther conditions: Invasive Breast Cancer, Estrogen Receptor Positive Breast CancerView official trial listing → -
Withdrawn NCT NCT01773551
Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response
University of California, Irvine Est. completion 2018-04 4 sitesOther conditions: Accessory; Breast TissueView official trial listing → -
Completed NCT NCT01780220
Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery
Not yet reported, Not yet reported UNICANCER 47 participants Est. completion 2022-01-07 5 sitesOther conditions: Biochemically-relapsing Prostate Adenocarcinoma Following Radical ProstatectomyView official trial listing → -
Completed NCT NCT01781338
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer
Not yet reported, Not yet reported Women's Cancer Study Group GmbH 4936 participants Est. completion 2025-01-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01791478
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 46 participants Est. completion 2022-10-06 2 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01796197
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Not yet reported Dana-Farber Cancer Institute 23 participants Est. completion 2026-01 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01800058
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 68 participants Est. completion 2018-12-21 3 sitesOther conditions: Patients With High-risk Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT01805271
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Not yet reported UNICANCER 1278 participants Est. completion 2030-06 2 sitesOther conditions: Primary Non-metastatic Breast Cancer, Who Remain Disease-freeView official trial listing → -
Status unknown NCT NCT01814449
Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer
Fudan University 130 participants Est. completion 2014-05 1 siteOther conditions: Breast Cancer, HypoxiaView official trial listing → -
Completed NCT NCT01822288
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 siteOther conditions: Menopausal SyndromesView official trial listing → -
Withdrawn NCT NCT01826838
Study of Dasatinib, Androgen Deprivation Therapy and Radiation
Not yet reported Brown University Est. completion 2013-04Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01831076
Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Not yet reported University of Colorado, Denver 36 participants Est. completion 2022-01-06 1 siteOther conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast CancerView official trial listing → -
Completed NCT NCT01867424
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2016-12-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01896050
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
University of Michigan Rogel Cancer Center 115 participants Est. completion 2014-08 1 siteOther conditions: Breast Cancer, Arthralgia, ObesityView official trial listing → -
Terminated NCT NCT01897441
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
Not yet reported Albert Einstein College of Medicine 31 participants Est. completion 2023-10-25 1 siteOther conditions: Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01904734
Clomid in Men With Low Testosterone With and Without Prior Treatment
Not yet reported Phoenix VA Health Care System 42 participants Est. completion 2018-10-31 1 siteOther conditions: Hypogonadism, MaleView official trial listing → -
Terminated NCT NCT01907009
A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)
Not yet reported, Not yet reported Barts & The London NHS Trust 29 participants Est. completion 2016-12-22 1 siteOther conditions: Castrate Resistant Prostate CancerView official trial listing → -
Completed NCT NCT01937052
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 329 participants Est. completion 2024-11-25 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01946165
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2017-07-28 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01963481
Exemestane and Cyclophosphamide for Metastatic Breast Cancer
Not yet reported NYU Langone Health 23 participants Est. completion 2017-10-01 1 siteOther conditions: Metastatic Beast CancerView official trial listing → -
Completed NCT NCT01973660
PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 151 participants Est. completion 2017-12 22 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT01990196
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
Not yet reported Jonsson Comprehensive Cancer Center 45 participants Est. completion 2026-09-30 1 siteOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT01994239
Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy
Not yet reported UNICANCER 120 participants Est. completion 2025-03 39 sites Stand-aloneOther conditions: Adenocarcinoma of ProstateView official trial listing → -
Completed NCT NCT01996046
FDG PET/CT in Breast Cancer Bone Mets
University of Pennsylvania 26 participants Est. completion 2026-07-31 1 siteOther conditions: Estrogen Receptor Positive Breast Cancer, Bone MetastasesView official trial listing → -
Terminated NCT NCT02000596
1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Not yet reported University of Maryland, Baltimore 2 participants Est. completion 2016-01 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02015273
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)
Merck KGaA, Darmstadt, Germany 82 participants Est. completion 2015-12-31 6 sitesOther conditions: Growth DisordersView official trial listing → -
Completed NCT NCT02015559
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus
Not yet reported Jonsson Comprehensive Cancer Center 61 participants Est. completion 2018-11-30 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Not yet reported Thomas Jefferson University 25 participants Est. completion 2040-01-01 1 siteOther conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT02035813
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
Not yet reported Prof. Wolfgang Janni 116 participants Est. completion 2024-01-10 1 siteOther conditions: HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal Female PatientsView official trial listing → -
Completed NCT NCT02040857
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02049671
Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet
The Leeds Teaching Hospitals NHS Trust 150 participants Est. completion 2020-07-30 1 siteOther conditions: Hypopituitary AdultsView official trial listing → -
Completed NCT NCT02057029
Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer
Not yet reported Yale University 96 participants Est. completion 2015-06 1 siteOther conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast CancerView official trial listing → -
Completed NCT NCT02064582
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Not yet reported University of Texas Southwestern Medical Center 7 participants Est. completion 2018-06-09 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02078531
A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients
National University Hospital, Singapore 130 participants Est. completion 2020-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02088710
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Philipps University Marburg 138 participants Est. completion 2020-02 1 siteOther conditions: Female Breast CancerView official trial listing → -
Status unknown NCT NCT02089854
Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Not yet reported Peking Union Medical College Hospital 800 participants 1 siteOther conditions: Female Breast CancerView official trial listing → -
Completed NCT NCT02090114
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 112 participants Est. completion 2021-11-11 2 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02097459
Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Not yet reported Peking Union Medical College Hospital 600 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02102490
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Not yet reported Eli Lilly and Company 132 participants Est. completion 2018-10-22 36 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02107287
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
Not yet reported Sergio Faria 105 participants Est. completion 2016-06 1 site Stand-aloneOther conditions: High Risk Prostate CancerView official trial listing → -
Completed NCT NCT02107391
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
Not yet reported SOTIO a.s. 63 participants Est. completion 2016-06 9 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02122198
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sitesCardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT02132949
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
Not yet reported Hoffmann-La Roche 401 participants Est. completion 2020-08-25 80 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02137083
A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer
Not yet reported Fudan University 22 participants Est. completion 2017-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT02140437
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
Not yet reported Fudan University Est. completion 2016-06Other conditions: Carcinoma Breast Stage IVView official trial listing → -
Completed NCT NCT02141659
A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer
Not yet reported Takeda 43 participants Est. completion 2017-04-20 6 sitesOther conditions: Hormone Treatment-naïve Participants With Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT02204098
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
Not yet reported Washington University School of Medicine 27 participants Est. completion 2028-08-31 1 siteOther conditions: Breast Cancer, Breast Carcinoma, Malignant Neoplasm of BreastView official trial listing → -
Status unknown NCT NCT02213991
Intraoperative Radiotherapy for Korean Patients With Breast Cancer
Not yet reported Gangnam Severance Hospital 215 participants Est. completion 2020-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02214004
Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women
Not yet reported Gangnam Severance Hospital 132 participants Est. completion 2019-06 14 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02216162
PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program
Not yet reported Hospices Civils de Lyon 12 participants Est. completion 2019-02-04 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02221999
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
Not yet reported, Not yet reported RenJi Hospital 250 participants Est. completion 2029-01 12 sitesOther conditions: Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast CancerView official trial listing → -
Completed NCT NCT02224313
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Not yet reported Intira Sriprasert 20 participants Est. completion 2018-08 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02228681
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Not yet reported GOG Foundation 74 participants Est. completion 2024-08-22 26 sitesOther conditions: Advanced, Persistent, or Recurrent Endometrial CancerView official trial listing → -
Status unknown NCT NCT02238509
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
Not yet reported Consorzio Oncotech 154 participants Est. completion 2017-10 36 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02256670
Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial
Not yet reported Yale University 100 participants Est. completion 2016-08 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02258464
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Bayer 99 participants Est. completion 2019-08-13 71 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02264743
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sitesOther conditions: Venous Thrombosis, Insulin ResistanceView official trial listing → -
Terminated NCT NCT02269670
Phase II Study of Everolimus Beyond Progression
Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT02269813
PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
Women's Cancer Study Group GmbH 452 participants Est. completion 2016-09-30 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02269982
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
Duke University 120 participants Est. completion 2019-04-30 5 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02274779
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer
Not yet reported Institut Cancerologie de l'Ouest 74 participants Est. completion 2024-07-22 2 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02284581
Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
Consorzio Oncotech 10000 participants Est. completion 2025-12 35 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02300675
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
Not yet reported Institut de Cancérologie de la Loire 352 participants Est. completion 2017-08 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02308020
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
Not yet reported Eli Lilly and Company 162 participants Est. completion 2019-11-08 44 sitesOther conditions: Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Brain MetastasesView official trial listing → -
Active, not recruiting NCT NCT02308085
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 518 participants Est. completion 2028-12 211 sitesOther conditions: Early Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02338310
Trial of Perioperative Endocrine Therapy - Individualising Care
Not yet reported Institute of Cancer Research, United Kingdom 4486 participants Est. completion 2034-04 128 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02344472
Detect V / CHEVENDO (Chemo vs. Endo)
Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02345772
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: HER2-positive Breast Cancer, ER-positive Breast CancerView official trial listing → -
Completed NCT NCT02347449
The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
Not yet reported Sunnybrook Health Sciences Centre 100 participants Est. completion 2016-09-30 1 siteOther conditions: Hormone Receptor Positive Malignant Neoplasm of BreastView official trial listing → -
Active, not recruiting NCT NCT02352883
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Not yet reported ECOG-ACRIN Cancer Research Group 368 participants Est. completion 2027-11 76 sitesOther conditions: Ductal Breast Carcinoma In SituView official trial listing → -
Completed NCT NCT02366494
Micro RNAs to Predict Response to Androgen Deprivation Therapy
Medical College of Wisconsin 42 participants Est. completion 2021-05-11 1 siteOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT02376413
Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Est. completion 2022-12Other conditions: Local Recurrence of Malignant Tumor of BreastView official trial listing → -
Completed NCT NCT02384408
Hormone Replacement Therapy on the Postmenopausal Endometrium
Not yet reported Universidade do Vale do Sapucai 100 participants Est. completion 2015-07 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02388308
Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
Institute of Cancer Research, United Kingdom 61 participants Est. completion 2018-06-18 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT02395627
Reversing Therapy Resistance With Epigenetic-Immune Modification
Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT02398773
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Not yet reported National Cancer Institute (NCI) 99 participants Est. completion 2026-12-31 25 sitesOther conditions: HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02400060
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 39 participants Est. completion 2020-06-30 4 sitesOther conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02400190
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
Not yet reported University of Michigan Rogel Cancer Center 202 participants Est. completion 2028-05 13 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT02401685
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer
Not yet reported University Hospitals of Derby and Burton NHS Foundation Trust 1900 participants Est. completion 2026-12-31 50 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02406794
Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors
Not yet reported, Not yet reported University of Malaga 156 participants Est. completion 2017-03 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02408536
Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
National Cancer Institute, Naples 150 participants Est. completion 2024-07 1 siteOther conditions: Low-grade Serous Ovarian Carcinoma, Recurrent Invasive Borderline Serous Ovarian CancerView official trial listing → -
Terminated NCT NCT02414776
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
Not yet reported Western Regional Medical Center 3 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02420353
Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears
Not yet reported University of Michigan 20 participants Est. completion 2018-10 1 siteOther conditions: Rupture of Anterior Cruciate LigamentView official trial listing → -
Completed NCT NCT02440230
Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients
Not yet reported Shanghai Jiao Tong University School of Medicine 110 participants Est. completion 2021-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02444390
Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor
Not yet reported UNICANCER 150 participants Est. completion 2022-07-01 12 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02448420
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 73 participants Est. completion 2023-11-30 35 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02449837
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
UNC Lineberger Comprehensive Cancer Center 162 participants Est. completion 2022-02-20 1 siteOther conditions: Circulating Tumor CellsView official trial listing → -
Completed NCT NCT02456571
CTC Immune Checkpoint
Duke University 38 participants Est. completion 2019-06-13 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02458716
Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
Not yet reported Rutgers, The State University of New Jersey 26 participants Est. completion 2020-01-14 3 sitesOther conditions: Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the BoneView official trial listing → -
Completed NCT NCT02479997
Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients
Not yet reported National Cancer Center, Korea 130 participants Est. completion 2018-03-27 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02480218
Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women
Sunnybrook Health Sciences Centre 47 participants Est. completion 2017-06 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT02483871
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Not yet reported Duke University Est. completion 2017-05-10 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02492607
Management of Low-risk (Grade I and II) DCIS
Not yet reported The Netherlands Cancer Institute 2500 participants Est. completion 2034-02-01 60 sitesOther conditions: DCISView official trial listing → -
Terminated NCT NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02503371
The Effect of In Vitro Fertilization on Coagulation Parameters as Measured by Thromboelastogram
Rabin Medical Center 46 participants Est. completion 2014-09 1 siteOther conditions: Fertilization in Vitro and Blood Coagulation FactorsView official trial listing → -
Completed NCT NCT02509871
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)
Not yet reported Centre Jean Perrin 33 participants Est. completion 2016-11 1 siteOther conditions: Hormonal Therapy, Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02513394
PALbociclib CoLlaborative Adjuvant Study
Not yet reported Alliance Foundation Trials, LLC. 5796 participants Est. completion 2028-12 437 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02530177
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center 546 participants Est. completion 2026-08 1 siteOther conditions: Non-Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02531516
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Not yet reported Aragon Pharmaceuticals, Inc. 1503 participants Est. completion 2028-12-29 263 sitesOther conditions: Prostatic NeoplasmsView official trial listing → -
Terminated NCT NCT02532400
Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
Not yet reported Ruijin Hospital 21 participants Est. completion 2019-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02549430
To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy
Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02549729
Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy
Not yet reported University of Sao Paulo 88 participants Est. completion 2016-08 1 siteOther conditions: Weak; Pelvic Floor, Weak; Muscle, Urinary IncontinenceView official trial listing → -
Terminated NCT NCT02560051
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Not yet reported The University of Texas Health Science Center, Houston 19 participants Est. completion 2017-09-14 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Status unknown NCT NCT02563691
Stereotactic Radiotherapy for Oligometastatic Prostate Cancer
Not yet reported, Not yet reported Sunnybrook Health Sciences Centre 90 participants Est. completion 2022-12 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT02564848
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65
Not yet reported Cedars-Sinai Medical Center 200 participants Est. completion 2029-03 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02580045
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
Duke University 3 participants Est. completion 2018-02-22 1 siteOther conditions: Metastatic Cancer Patients on an Anti-cancer Therapy, Advanced Cancer, Brain MetastasisView official trial listing → -
Status unknown NCT NCT02597868
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2017-07 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02598310
Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer
Not yet reported Osaka Medical College 30 participants Est. completion 2018-11-30 1 siteOther conditions: Breast Cancer, Estrogen Receptor Negative Neoplasm, HER-2 Positive Breast CancerView official trial listing → -
Status unknown NCT NCT02615223
Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
Not yet reported Tianjin Medical University Cancer Institute and Hospital 120 participants Est. completion 2018-12 1 siteOther conditions: Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT02616562
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Not yet reported Novo Nordisk A/S 76 participants Est. completion 2024-09-26 89 sitesOther conditions: Growth Hormone Disorder, Growth Hormone Deficiency in ChildrenView official trial listing → -
Status unknown NCT NCT02617108
Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11 Stand-aloneOther conditions: Uterine SeptumView official trial listing → -
Active, not recruiting NCT NCT02623972
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2026-12 2 sitesOther conditions: Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Completed NCT NCT02627079
ICanSTEP : Increasing Physical Activity With Text Messaging
Not yet reported Duke University 30 participants Est. completion 2018-05-21 1 siteOther conditions: A Diagnosis of Any Hematologic or Solid MalignancyView official trial listing → -
Status unknown NCT NCT02646735
Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02651896
Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer
Hospital Sirio-Libanes 130 participants Est. completion 2019-12 2 sitesOther conditions: Prostatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT02653755
The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Not yet reported Dana-Farber Cancer Institute 671 participants Est. completion 2030-05-15 6 sitesOther conditions: Breast Cancer RadiationView official trial listing → -
Completed NCT NCT02654119
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Not yet reported University of Nebraska 20 participants Est. completion 2025-12-08 3 sites Stand-aloneOther conditions: HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02669576
Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy
Not yet reported Universität Duisburg-Essen 68 participants Est. completion 2022-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02676986
Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer
Not yet reported Queen Mary University of London 221 participants Est. completion 2016-12-31 41 sitesOther conditions: Primary Breast Cancer ER+ve, Primary Breast Cancer AR+ve TNBNView official trial listing → -
Withdrawn NCT NCT02678520
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients
Not yet reported University of Kansas Medical Center Est. completion 2016-02 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT02685397
Management of Castration-Resistant Prostate Cancer with Oligometastases
Not yet reported, Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 102 participants Est. completion 2041-08 11 sitesOther conditions: Castration-resistant Prostate Cancer Patients with OligometastasesView official trial listing → -
Status unknown NCT NCT02690480
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT02693002
Estrogen Diastolic Heart Failure
Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 siteOther conditions: MenopauseView official trial listing → -
Active, not recruiting NCT NCT02712723
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Not yet reported Qamar Khan 121 participants Est. completion 2026-12 13 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02716974
A Study of Definitive Therapy to Treat Prostate Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26 participants Est. completion 2022-04 3 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT02719990
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)
Not yet reported Versartis Inc. 36 participants Est. completion 2018-01-11Other conditions: Adult Growth Hormone Deficiency (AGHD)View official trial listing → -
Completed NCT NCT02720770
Growth Hormone Treatment in Children With Hypophosphatemic Rickets
Not yet reported, Not yet reported Bicetre Hospital 19 participants Est. completion 2011-01Other conditions: X Linked Hypophosphatemic RicketsView official trial listing → -
Terminated NCT NCT02734615
Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers
Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2021-09-13 10 sitesOther conditions: Advanced or Metastatic ER+ Breast CancerView official trial listing → -
Completed NCT NCT02742051
A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40 participants Est. completion 2020-03-14 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02753686
Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sitesOther conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT02755038
Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)
Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02758756
Pilot Study on Energy Therapy or Massage to Reduce Fatigue
Not yet reported University of Rochester 87 participants Est. completion 2019-05 1 siteOther conditions: FatigueView official trial listing → -
Completed NCT NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sitesOther conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02778685
Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer
Not yet reported City of Hope Medical Center 47 participants Est. completion 2026-03-30 7 sitesOther conditions: Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02785861
Step by Step After Cancer
Not yet reported Centre Hospitalier Universitaire, Amiens 17 participants Est. completion 2026-02-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02791750
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
Institut de Cancérologie de Lorraine 150 participants Est. completion 2017-06-03 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02823262
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Not yet reported Beth Israel Deaconess Medical Center 65 participants Est. completion 2022-03 2 sitesOther conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Completed NCT NCT02841137
Efficacy Study of Progesterone Tablet in Post-menopausal Women
Not yet reported IBSA Institut Biochimique SA 80 participants Est. completion 2018-04-25 1 siteOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT02855632
The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Sir Run Run Shaw Hospital 240 participants Est. completion 2019-12 1 siteOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT02858063
Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner
Centre Oscar Lambret 1045 participants Est. completion 2013-11-27 25 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02876848
A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 120 participants Est. completion 2018-09 1 siteOther conditions: Breast Neoplasms, Medication AdherenceView official trial listing → -
Completed NCT NCT02878057
Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
Not yet reported Peking University Cancer Hospital & Institute 30 participants Est. completion 2020-09-02Other conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02889874
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
Not yet reported Breast Cancer Trials, Australia and New Zealand 1167 participants Est. completion 2028-04 68 sitesOther conditions: Early Stage Breast CarcinomaView official trial listing → -
Completed NCT NCT02894398
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Status unknown NCT NCT02896504
Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients
Kessler Foundation 60 participants Est. completion 2018-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02907372
Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer
Not yet reported Centre Francois Baclesse 163 participants Est. completion 2022-12 6 sitesOther conditions: Metastatic Castration-resistant Prostate Cancer (CRPCa)View official trial listing → -
Status unknown NCT NCT02913859
Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
Not yet reported University Hospital Sestre Milosrdnice 60 participants Est. completion 2020-12 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT02926911
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
Not yet reported Alliance Foundation Trials, LLC. 997 participants Est. completion 2030-07 141 sitesOther conditions: DCIS, Ductal Carcinoma in SituView official trial listing → -
Status unknown NCT NCT02931591
Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children
Not yet reported Cambridge University Hospitals NHS Foundation Trust 24 participants Est. completion 2020-06Other conditions: Small for Gestational AgeView official trial listing → -
Completed NCT NCT02935920
A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy
Not yet reported Vejle Hospital 134 participants Est. completion 2019-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02941926
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
Not yet reported Novartis Pharmaceuticals 3246 participants Est. completion 2022-11-09 495 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02947685
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Not yet reported Alliance Foundation Trials, LLC. 518 participants Est. completion 2030-12-31 108 sitesOther conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast CancerView official trial listing → -
Status unknown NCT NCT02950207
Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100
Fondazione del Piemonte per l'Oncologia 180 participants Est. completion 2019-01 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02971748
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
Not yet reported M.D. Anderson Cancer Center 36 participants Est. completion 2027-12-31 1 siteOther conditions: Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT02977091
Fitness Level in Short Stature Children and After Growth Hormone Treatment
Meir Medical Center 50 participants Est. completion 2019-03-01 1 siteOther conditions: FitnessView official trial listing → -
Status unknown NCT NCT02982421
The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors
Not yet reported Rabin Medical Center 20 participants Est. completion 2017-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02992730
Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer
Georgetown University 630 participants Est. completion 2019-12 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT02995772
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02997995
Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Not yet reported UNICANCER 61 participants Est. completion 2020-08-28 29 sitesOther conditions: Breast Cancer, Estrogen Receptor Positive Tumor, Menopause, Hormone AntagonistView official trial listing → -
Status unknown NCT NCT03005561
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
Not yet reported Prof. Eli Hershkovitz 200 participants Est. completion 2018-03Other conditions: Growth Hormone TreatmentView official trial listing → -
Completed NCT NCT03007992
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
Not yet reported Johannes Gutenberg University Mainz 9 participants Est. completion 2019-03-02 8 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03016741
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Not yet reported Northwestern University 100 participants Est. completion 2029-08 5 sitesOther conditions: Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Hormone-Refractory Prostate CancerView official trial listing → -
Completed NCT NCT03033121
Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children
Not yet reported University of Palermo 32 participants Est. completion 2017-01-01 1 siteOther conditions: Growth Hormone TreatmentView official trial listing → -
Completed NCT NCT03043807
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26 participants Est. completion 2022-10-17 2 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03045653
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer
Not yet reported Sun Yat-sen University 30 participants Est. completion 2019-02-21 1 siteOther conditions: Breast Cancer MetastaticView official trial listing → -
Withdrawn NCT NCT03058939
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
Not yet reported University of Chicago Est. completion 2019-06 1 siteOther conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage IIIView official trial listing → -
Completed NCT NCT03065010
Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer
Not yet reported Biocad 6 participants Est. completion 2018-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03065621
Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)
Not yet reported Jules Bordet Institute 100 participants Est. completion 2023-02-01 5 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Terminated NCT NCT03066154
Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer
Not yet reported The Netherlands Cancer Institute 24 participants Est. completion 2022-08 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT03078036
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study
AstraZeneca 873 participants Est. completion 2019-05-20 98 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT03081234
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer
Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT03092635
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy
Not yet reported Medical University of South Carolina 9 participants Est. completion 2022-04-22 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03099200
An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer
Hoffmann-La Roche 300 participants Est. completion 2017-03-17 14 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT03119857
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
Not yet reported Göteborg University 349 participants Est. completion 2023-04 5 sitesOther conditions: Prostatic NeoplasmsView official trial listing → -
Terminated NCT NCT03147040
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
Not yet reported The Netherlands Cancer Institute 23 participants Est. completion 2022-07-01 4 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03147287
Palbociclib After CDK and Endocrine Therapy (PACE)
Not yet reported Dana-Farber Cancer Institute 220 participants Est. completion 2026-12-30 22 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03161353
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03162172
Growth Hormone (GH) in Congenital Adrenal Hyperplasia
Hospices Civils de Lyon 25 participants Est. completion 2016-03-15 1 siteOther conditions: Adrenal Hyperplasia, CongenitalView official trial listing → -
Completed NCT NCT03162523
Experiences With HDR-brachytherapy in Norway
Oslo University Hospital 325 participants Est. completion 2016-10-15 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03176238
Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sitesOther conditions: Post Menopausal Breast CancerView official trial listing → -
Completed NCT NCT03184090
Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC
Not yet reported MedSIR 33 participants Est. completion 2020-10-27 15 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03186599
Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer
Not yet reported Gachon University 200 participants Est. completion 2018-10-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03195192
Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer
Not yet reported Side-Out Foundation 28 participants Est. completion 2020-06-30 8 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03204734
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2021-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03213925
Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer
Not yet reported Instituto do Cancer do Estado de São Paulo 1 participants Est. completion 2025-07-01 1 siteOther conditions: Breast Cancer, Radiation TherapyView official trial listing → -
Completed NCT NCT03227328
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO
Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 52 participants Est. completion 2022-07-01 20 sitesOther conditions: Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Negative Breast CancerView official trial listing → -
Completed NCT NCT03235427
The CAROLE (CArdiac Related Oncologic Late Effects) Study
Northwell Health 201 participants Est. completion 2018-06-26 1 siteCardiovascular disease Other conditions: Cardiac Disease, Cardiac Toxicity, Radiation, Radiation Therapy, Atherosclerotic Heart Disease, Cardiotoxicity, Breast Cancer, Lung Cancer, Lymphoma, Cancer, Carcinoma, Intraductal, NoninfiltratingView official trial listing → -
Completed NCT NCT03236545
Menopause Effects on Vascular Function
Not yet reported University of Delaware 48 participants Est. completion 2022-11-01 1 siteOther conditions: Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT03238196
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 35 participants Est. completion 2024-03-20 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT03238703
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Not yet reported Fred Hutchinson Cancer Center Est. completion 2025-03-14 1 siteOther conditions: HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal, Stage 0 Breast Cancer, Stage IA Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03241537
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer
Not yet reported Samsung Medical Center 61 participants Est. completion 2026-12-14 1 siteOther conditions: Prostate NeoplasmView official trial listing → -
Completed NCT NCT03259711
Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase
Groupe Hospitalier Pitie-Salpetriere 20000 participants Est. completion 2017-08-14 1 siteOther conditions: Cardiac AffectionsView official trial listing → -
Completed NCT NCT03270969
A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women
Not yet reported University of Nebraska 15 participants Est. completion 2018-09-10 1 siteOther conditions: HIV PreventionView official trial listing → -
Active, not recruiting NCT NCT03281902
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
Mayo Clinic 68 participants Est. completion 2028-03-04 3 sitesOther conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Active, not recruiting NCT NCT03285412
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
Not yet reported Massachusetts General Hospital 120 participants Est. completion 2026-10 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03288103
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2023-08-31 1 siteOther conditions: Short StatureView official trial listing → -
Status unknown NCT NCT03294122
Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 400 participants Est. completion 2019-12-31 1 siteOther conditions: Prostate Cancer, Head and Neck CancerView official trial listing → -
Status unknown NCT NCT03301389
Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)
Yonsei University 2000 participants Est. completion 2025-01 1 siteOther conditions: Chemotherapy Induced CardiotoxicityView official trial listing → -
Completed NCT NCT03308201
Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer
Not yet reported Tianjin Hemay Pharmaceutical Co., Ltd 55 participants Est. completion 2023-03-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03327207
Exploring Interactions Between Growth Hormone and the Microbiome
Rambam Health Care Campus 200 participants Est. completion 2021-11 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT03355157
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03361735
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Not yet reported City of Hope Medical Center 25 participants Est. completion 2027-01-06 1 siteOther conditions: Prostate AdenocarcinomaView official trial listing → -
Status unknown NCT NCT03373708
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Not yet reported, Not yet reported Zhiyong Yu 200 participants Est. completion 2019-12-20Other conditions: Breast Cancer, Chemotherapy, Endocrine Breast DiseasesView official trial listing → -
Status unknown NCT NCT03395327
Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer
Centre Hospitalier Departemental Vendee 50 participants Est. completion 2020-05-15 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03420105
Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep
Not yet reported Centre Francois Baclesse 75 participants Est. completion 2020-03-06 2 sitesOther conditions: Breast Cancer, Memory DisordersView official trial listing → -
Active, not recruiting NCT NCT03425838
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sitesOther conditions: Breast Neoplasm FemaleView official trial listing → -
Terminated NCT NCT03430466
Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
Not yet reported Kyoto Breast Cancer Research Network 1 participants Est. completion 2018-07-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03432780
Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer
Not yet reported Spanish Oncology Genito-Urinary Group 134 participants Est. completion 2023-11-14Other conditions: Prostate Cancer Stage III, Prostate Cancer Stage IVView official trial listing → -
Active, not recruiting NCT NCT03439735
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45 participants Est. completion 2027-11-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03442504
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03447886
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
Dana-Farber Cancer Institute 17 participants Est. completion 2018-08-27 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03458559
Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy
Not yet reported Amsterdam UMC, location VUmc 402 participants Est. completion 2024-05-16 1 siteOther conditions: Prostate Cancer Metastatic to BoneView official trial listing → -
Completed NCT NCT03462251
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast CancerView official trial listing → -
Status unknown NCT NCT03489473
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
Radboud University Medical Center 40 participants Est. completion 2021-12-01Other conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT03493854
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
Not yet reported Hoffmann-La Roche 500 participants Est. completion 2023-06-02 107 sitesOther conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT03494400
Aerobic Training in Treatment for Breast Cancer
Not yet reported Universidade Estadual Paulista Júlio de Mesquita Filho 6 participants Est. completion 2020-11-30 1 siteOther conditions: Cancer of Breast, HealthyView official trial listing → -
Active, not recruiting NCT NCT03503799
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
North Eastern German Society of Gynaecological Oncology 1191 participants Est. completion 2032-10-01 40 sitesOther conditions: Primary Invasive Breast Cancer, Estrogen Receptor Positive Tumor, Human Epidermal Growth Factor Receptor 2 Negative TumorView official trial listing → -
Completed NCT NCT03514654
MIAMI Safe Surgery for Multiple Breast Cancers
Not yet reported University College, London 4 participants Est. completion 2020-10-31 7 sitesOther conditions: Breast Cancer, UnilateralView official trial listing → -
Terminated NCT NCT03519178
A Study of PF-06873600 in People With Cancer
Not yet reported, Not yet reported Pfizer 155 participants Est. completion 2024-10-30 54 sitesOther conditions: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerView official trial listing → -
Completed NCT NCT03523351
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 78 participants Est. completion 2024-04-18 9 sitesOther conditions: Metastatic Solid Tumors of Metastatic DiseaseView official trial listing → -
Completed NCT NCT03523572
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
Not yet reported Daiichi Sankyo 86 participants Est. completion 2023-09-12 29 sites Stand-aloneOther conditions: Breast Cancer, Urothelial CarcinomaView official trial listing → -
Completed NCT NCT03530215
Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)
Groupe Hospitalier Pitie-Salpetriere 500000 participants Est. completion 2023-04-08 1 siteOther conditions: Cardiac Disease, CancerView official trial listing → -
Status unknown NCT NCT03549663
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108 participants Est. completion 2021-10 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Terminated NCT NCT03553602
HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer
Not yet reported, Not yet reported Loyola University 3 participants Est. completion 2024-07-26 1 site Stand-aloneOther conditions: Prostate Cancer - RecurrentView official trial listing → -
Completed NCT NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 siteOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast CarcinomaView official trial listing → -
Completed NCT NCT03554265
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
Not yet reported The University of Texas Medical Branch, Galveston 72 participants Est. completion 2023-10-04 1 siteOther conditions: Traumatic Brain Injury, Fatigue, Cognitive Impairment, COVID-19View official trial listing → -
Completed NCT NCT03555877
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 siteOther conditions: Breast Cancer MetastaticView official trial listing → -
Status unknown NCT NCT03556800
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT03556904
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
Not yet reported University of Michigan Rogel Cancer Center 14 participants Est. completion 2023-07-28 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03557268
Pubertal Blockade and Hormone Therapy in Transgender Youth
University of Colorado, Denver 19 participants Est. completion 2020-09-09 1 siteOther conditions: Gender Identity, Gender Dysphoria, Gender Identity Disorder in Adolescence and AdulthoodView official trial listing → -
Active, not recruiting NCT NCT03561961
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
Not yet reported Tata Memorial Centre 526 participants Est. completion 2035-03 1 site Stand-aloneOther conditions: Prostate AdenocarcinomaView official trial listing → -
Status unknown NCT NCT03568149
Pelvic Congestion Syndrome and Endometriosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 160 participants Est. completion 2019-08 1 siteOther conditions: Pelvic Congestive Syndrome, EndometriosisView official trial listing → -
Active, not recruiting NCT NCT03573648
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03579680
De-implementation of Low Value Castration for Men With Prostate Cancer
Not yet reported University of Michigan 60 participants Est. completion 2023-04-06 1 siteOther conditions: Cancer of ProstateView official trial listing → -
Status unknown NCT NCT03587285
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer
Not yet reported, Not yet reported Guangzhou University of Traditional Chinese Medicine 11 participants Est. completion 2021-07-31 1 site Stand-aloneOther conditions: Prostatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT03609047
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 366 participants Est. completion 2026-09-30 73 sitesOther conditions: Breast Cancer Stage II, Breast Cancer Stage IIIView official trial listing → -
Completed NCT NCT03620734
Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women
Thai Red Cross AIDS Research Centre 40 participants Est. completion 2019-10-01 1 siteOther conditions: PrEP and ARTView official trial listing → -
Terminated NCT NCT03636776
Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer
Not yet reported Institut Cancerologie de l'Ouest 60 participants Est. completion 2022-01-11 2 sitesOther conditions: Metastatic Breast Cancer, Positive Hormonal ReceptorsView official trial listing → -
Completed NCT NCT03644186
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
Not yet reported ETOP IBCSG Partners Foundation 147 participants Est. completion 2023-04-14 54 sites Stand-aloneOther conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast CancerView official trial listing → -
Status unknown NCT NCT03651427
Cross-sex Hormone Therapy and Neuronal Plasticity
Not yet reported Hospital de Clinicas de Porto Alegre 30 participants Est. completion 2019-03-30 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Completed NCT NCT03652623
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study
Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 siteOther conditions: HIV/AIDS, Gender, Behavior and Behavior MechanismsView official trial listing → -
Completed NCT NCT03654638
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 25 participants Est. completion 2022-03-09 1 siteOther conditions: Prostate AdenocarcinomaView official trial listing → -
Completed NCT NCT03665077
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome
Not yet reported University of Arizona 28 participants Est. completion 2022-06-15 1 site Stand-aloneOther conditions: Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS), Breast CancerView official trial listing → -
Completed NCT NCT03672396
Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer
Not yet reported UNC Lineberger Comprehensive Cancer Center 22 participants Est. completion 2019-12-31 2 sitesOther conditions: Castration-resistant Prostate Cancer, Androgen Deprivation TherapyView official trial listing → -
Completed NCT NCT03672617
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
Novo Nordisk A/S 321 participants Est. completion 2019-04-25 1 siteOther conditions: Growth Hormone Deficiency in ChildrenView official trial listing → -
Completed NCT NCT03676257
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Institut Bergonié 20033 participants Est. completion 2023-12-01 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03685331
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 siteOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 MutationView official trial listing → -
Completed NCT NCT03690765
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Abbott 350 participants Est. completion 2020-05-29 21 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03691493
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT03695341
500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI
Fudan University 130 participants Est. completion 2019-05-15 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03697200
Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings
Not yet reported Johns Hopkins University 102 participants Est. completion 2020-12-30 1 siteOther conditions: Aromatase Inhibitor, Musculoskeletal Symptoms, Postmenopausal Breast Cancer SurvivorsView official trial listing → -
Active, not recruiting NCT NCT03701334
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
Not yet reported Novartis Pharmaceuticals 5101 participants Est. completion 2030-05-29 387 sitesOther conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT03718260
PSMA-PET Registry for Recurrent Prostate Cancer
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 9684 participants Est. completion 2026-06-15 7 sitesOther conditions: Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT03719495
Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer
Duke University 68 participants Est. completion 2023-07-31 1 siteOther conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HealthyView official trial listing → -
Active, not recruiting NCT NCT03725059
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03749421
Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer
Dana-Farber Cancer Institute 60 participants Est. completion 2025-08-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03750396
Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer
Not yet reported Gangnam Severance Hospital 110 participants Est. completion 2025-07-31 1 siteOther conditions: Breast Cancer, Recurrent Breast Cancer, Stereotactic Body Radiotherapy, Estrogen Receptor Positive Tumor, Her2-negative Tumor, SurgeryView official trial listing → -
Completed NCT NCT03761420
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome
St. Olavs Hospital 1411 participants Est. completion 2021-04-01 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Active, not recruiting NCT NCT03767244
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Not yet reported Janssen Research & Development, LLC 2517 participants Est. completion 2028-10-13 203 sitesOther conditions: Prostatic NeoplasmsView official trial listing → -
Status unknown NCT NCT03772353
Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
Not yet reported, Not yet reported Fudan University 59 participants Est. completion 2025-12-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03776045
PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)
Not yet reported University of East Anglia 50 participants Est. completion 2016-02-03Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03778359
Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis
Taipei Veterans General Hospital, Taiwan 5000 participants Est. completion 2018-10-18 1 siteOther conditions: Endometriosis, AdenomyosisView official trial listing → -
Status unknown NCT NCT03786575
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
Not yet reported Peking Union Medical College 50 participants Est. completion 2021-12-31 1 siteOther conditions: Breast Neoplasm Female, Therapeutics, MutationView official trial listing → -
Terminated NCT NCT03795012
Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients
Not yet reported MedSIR 22 participants Est. completion 2021-03-31 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03798197
Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers
Not yet reported Donesta Bioscience 28 participants Est. completion 2019-04-06 1 siteOther conditions: Food-effectView official trial listing → -
Completed NCT NCT03809988
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Active, not recruiting NCT NCT03818100
Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible
CCTU- Cancer Theme 43 participants Est. completion 2026-10-15 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sitesOther conditions: Breast Cancer RecurrentView official trial listing → -
Completed NCT NCT03822429
Cumulative Live Birth Rate (CLBR) After a Complete IVF Cycle: a Single Center Retrospective Study
Istituto Clinico Humanitas 6375 participants Est. completion 2015-12-31Other conditions: ART, Fertility DisordersView official trial listing → -
Completed NCT NCT03837496
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
Not yet reported Massachusetts General Hospital 100 participants Est. completion 2021-12-01 1 site Stand-aloneOther conditions: Breast Cancer, Adherence, MedicationView official trial listing → -
Completed NCT NCT03839823
Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 222 participants Est. completion 2023-05-10 50 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03849573
A Web-Based Tool to Improve Breast Cancer Survivorship
Not yet reported Northwestern University 84 participants Est. completion 2022-05-01 1 siteOther conditions: Breast Cancer, Hormone Dependent Neoplasms, Adherence to Hormone TherapyView official trial listing → -
Status unknown NCT NCT03864250
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124 participants Est. completion 2021-11 1 siteOther conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical TrialView official trial listing → -
Completed NCT NCT03870399
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sitesOther conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive TumorView official trial listing → -
Status unknown NCT NCT03873428
Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES
Not yet reported Centre Georges Francois Leclerc 25 participants Est. completion 2025-10-18 2 sitesOther conditions: FES TEP in Detection of Estrogen ReceptorsView official trial listing → -
Completed NCT NCT03896984
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).
Bayer 346 participants Est. completion 2020-12-14 1 siteOther conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)View official trial listing → -
Active, not recruiting NCT NCT03900637
PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
Not yet reported Seoul National University Hospital 122 participants Est. completion 2028-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03906669
A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.
Not yet reported St Vincent's Hospital 200 participants Est. completion 2024-04 1 siteOther conditions: Early-stage Breast Cancer, Hormone Receptor Positive TumorView official trial listing → -
Active, not recruiting NCT NCT03917082
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
Not yet reported British Columbia Cancer Agency 290 participants Est. completion 2029-05-01 1 siteOther conditions: Breast Cancer Female, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT03928288
Cabergoline for the Treatment of Chronic Pain Due to Endometriosis
Not yet reported Boston Children's Hospital 129 participants Est. completion 2026-01-14 6 sitesOther conditions: EndometriosisView official trial listing → -
Status unknown NCT NCT03939156
Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer
European Institute of Oncology 450 participants Est. completion 2023-12-31 1 siteOther conditions: Breast Cancer, Endocrine Breast DiseasesView official trial listing → -
Completed NCT NCT03945812
Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer
Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 siteOther conditions: Infertility, Frozen Embryo Transfer (FET)View official trial listing → -
Completed NCT NCT03948568
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
Not yet reported Ottawa Hospital Research Institute 262 participants Est. completion 2022-04-09 1 siteOther conditions: Early-stage Breast CancerView official trial listing → -
Completed NCT NCT03949270
Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer
Not yet reported Yale University 400 participants Est. completion 2023-11-01 1 siteOther conditions: Breast Cancer, Adherence, Medication, Side EffectView official trial listing → -
Completed NCT NCT03955627
REJOIN Trial for Older Breast Cancer Survivors
Not yet reported Wake Forest University Health Sciences 12 participants Est. completion 2025-07-29 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Active, not recruiting NCT NCT03959891
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
Not yet reported Massachusetts General Hospital 77 participants Est. completion 2027-08 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03960593
Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological Malignancy
Assistance Publique Hopitaux De Marseille 500 participants Est. completion 2024-05-06 1 siteOther conditions: Cancer and / or Hematological MalignancyView official trial listing → -
Enrolling by invitation NCT NCT03972345
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Novo Nordisk A/S 750 participants Est. completion 2031-06-30 1 siteOther conditions: Growth Hormone Deficiency in Children, Born Small for Gestational AgeView official trial listing → -
Completed NCT NCT03980093
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
Not yet reported University of Colorado, Boulder 88 participants Est. completion 2020-08-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03997539
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 256 participants Est. completion 2021-12-30Other conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04002570
Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients
Clinica Luganese Moncucco 13 participants Est. completion 2020-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04003207
Growth Hormone Treatment in Children With Phelan McDermid Syndrome
Not yet reported Swathi Sethuram 6 participants Est. completion 2020-06-05 1 siteOther conditions: Phelan McDermid SyndromeView official trial listing → -
Status unknown NCT NCT04012918
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04024462
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer
Not yet reported Hoffmann-La Roche 200 participants Est. completion 2026-01-19 18 sitesOther conditions: HER2-positive Early Breast CancerView official trial listing → -
Status unknown NCT NCT04045392
Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients
Not yet reported Gangnam Severance Hospital 78 participants Est. completion 2021-08Other conditions: Breast Cancer, ObesityView official trial listing → -
Completed NCT NCT04048252
Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
Centre Hospitalier Universitaire de Nīmes 18 participants Est. completion 2021-07-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT04049747
Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer
Not yet reported Imperial College London 100 participants Est. completion 2023-03-20 10 sites Stand-aloneOther conditions: Prostate Cancer, Non-metastatic Prostate Cancer, Prostate AdenocarcinomaView official trial listing → -
Status unknown NCT NCT04050592
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 siteCardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT04054557
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
Not yet reported Thomas Jefferson University 305 participants Est. completion 2024-12-06 5 sitesOther conditions: Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage III Breast Cancer AJCC v7View official trial listing → -
Active, not recruiting NCT NCT04055493
Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC
Not yet reported Women's Cancer Study Group GmbH 1684 participants Est. completion 2027-07-31 86 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Terminated NCT NCT04059484
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT04066283
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 siteOther conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive BehaviorView official trial listing → -
Active, not recruiting NCT NCT04070209
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 66 participants Est. completion 2030-11 11 sites Stand-aloneOther conditions: Metastatic Prostate Cancer, Castration-resistant Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT04071236
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
Not yet reported, Not yet reported National Cancer Institute (NCI) 90 participants Est. completion 2027-04-30 32 sitesOther conditions: Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Completed NCT NCT04077138
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development
Hektoen Institute for Medical Research 80 participants Est. completion 2023-11-30 3 sitesOther conditions: HIV/AIDS, Gender, Behavior and Behavior MechanismsView official trial listing → -
Completed NCT NCT04077151
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project
Not yet reported Hektoen Institute for Medical Research 51 participants Est. completion 2023-11-30 1 siteOther conditions: HIV/AIDS, Gender, Behavior and Behavior MechanismsView official trial listing → -
Status unknown NCT NCT04086875
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
Not yet reported Thomas Jefferson University 332 participants Est. completion 2024-09-24 7 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Positive Tumor, Progesterone Receptor Positive Tumor, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT04095390
A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
Not yet reported Jinming Yu 60 participants Est. completion 2022-08-30 1 siteOther conditions: Metastatic Breast Cancer, HER2-positive Breast CancerView official trial listing → -
Completed NCT NCT04097756
A Phase I Study of LX-039 Tablets
Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 44 participants Est. completion 2023-02-07 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT04109066
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
Not yet reported Bristol-Myers Squibb 521 participants Est. completion 2023-12-27 240 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04116827
Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
Samsung Medical Center 20 participants Est. completion 2020-12-31 1 siteOther conditions: Sleep Disorder, Breast CancerView official trial listing → -
Completed NCT NCT04128488
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Massachusetts General Hospital 33 participants Est. completion 2024-03-28 1 siteCardiovascular disease Other conditions: Transgender Women, HIV/AIDS, Metabolic Disease, CoagulopathyView official trial listing → -
Active, not recruiting NCT NCT04134598
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
Not yet reported Azienda Ospedaliero-Universitaria Careggi 926 participants Est. completion 2030-03-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04139772
Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
Not yet reported National Cancer Institute, Naples 18 participants Est. completion 2024-07-01 1 siteOther conditions: Metastatic Castration-resistent Prostate CancerView official trial listing → -
Status unknown NCT NCT04152057
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 siteOther conditions: Breast Cancer, HER2 Positive, Combination ChemotherapyView official trial listing → -
Completed NCT NCT04168814
Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study
Universidad Pontificia Comillas 586 participants Est. completion 2020-12-15 11 sitesOther conditions: Malnutrition, Oncologic Complications, Oncology, Quality of LifeView official trial listing → -
Status unknown NCT NCT04176809
Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer
Not yet reported Centre Georges Francois Leclerc 342 participants Est. completion 2025-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04188275
CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION
Azienda Ospedaliero-Universitaria Careggi 46 participants Est. completion 2022-06-30 1 siteOther conditions: D011471, D064129, D035683, D009360, D014408View official trial listing → -
Completed NCT NCT04200001
Evaluation of Sexual Quality of Life for Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 45 participants Est. completion 2020-07-31 1 siteOther conditions: Breast Cancer, Cancer, Quality of LifeView official trial listing → -
Status unknown NCT NCT04212702
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04220398
Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer
Not yet reported RenJi Hospital 475 participants Est. completion 2024-12-31Other conditions: Prostate Cancer, Chemotherapy Effect, Hormone Sensitive Prostate Cancer, Locally Advanced Prostate CarcinomaView official trial listing → -
Completed NCT NCT04237467
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men
University of Colorado, Denver 16 participants Est. completion 2023-12-31 1 siteOther conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Blood Pressure, Lipid Disorder, Appetitive BehaviorView official trial listing → -
Completed NCT NCT04244123
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
Manchester University NHS Foundation Trust 43 participants Est. completion 2023-01-05 1 siteOther conditions: Short Stature, Growth Hormone TreatmentView official trial listing → -
Completed NCT NCT04246606
Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer
UNICANCER 155 participants Est. completion 2023-11-01 1 siteOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT04247633
High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
Not yet reported Samsung Medical Center 578 participants Est. completion 2025-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04258163
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04272801
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
Not yet reported Shayna Showalter, MD 84 participants Est. completion 2026-06-01 2 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT04276272
D4 Choline Breast PET/CT
Imperial College London 6 participants Est. completion 2023-11-03 1 siteOther conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04282031
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
Not yet reported, Not yet reported Beta Pharma (Suzhou) Co., Ltd. 224 participants Est. completion 2025-06-30 1 siteOther conditions: Advanced Solid Tumor, HR+/HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT04282876
Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer
Aarhus University Hospital 60 participants Est. completion 2025-10-31 1 siteOther conditions: Bladder Cancer, Radiation Therapy Complication, Quality of LifeView official trial listing → -
Completed NCT NCT04283656
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
Not yet reported Thomas Jefferson University 8 participants Est. completion 2022-12-30 1 siteOther conditions: Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT04300790
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sitesOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT04301375
Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)
Not yet reported David Garcia Cinca 27 participants Est. completion 2027-07-15 1 siteOther conditions: Mammary CancerView official trial listing → -
Active, not recruiting NCT NCT04302454
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
Not yet reported University Medical Center Groningen 280 participants Est. completion 2027-12-01 13 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT04305093
Data Mining: Precision Analytical Retrospective Data Correlation
Precision Analytical, Inc. 144561 participants Est. completion 2023-03-28 1 siteOther conditions: Obesity; Endocrine, Hormone DisturbanceView official trial listing → -
Terminated NCT NCT04305236
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 siteOther conditions: Breast Neoplasm, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Withdrawn NCT NCT04309760
Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
Not yet reported Hôpital le Vinatier Est. completion 2022-03-15Other conditions: Gender DysphoriaView official trial listing → -
Completed NCT NCT04315012
Training With Mobile Application in Breast Cancer
Not yet reported Izmir Bakircay University 64 participants Est. completion 2018-04-17 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04318223
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
Not yet reported Consorzio Oncotech 168 participants Est. completion 2023-07-31 19 sitesOther conditions: Metastatic Breast Cancer, Locally Advanced Breast CancerView official trial listing → -
Completed NCT NCT04340713
The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy
Not yet reported Fudan University 95 participants Est. completion 2020-02-29 1 site Stand-aloneOther conditions: Information SupportView official trial listing → -
Completed NCT NCT04341324
Effect of ADT in Chinese Male With Prostate Cancer
Chinese University of Hong Kong 60 participants Est. completion 2019-12-04Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT04354896
The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism
Not yet reported Insel Gruppe AG, University Hospital Bern 322 participants Est. completion 2018-05-04 5 sitesOther conditions: Subclinical Hypothyroidism, SarcopeniaView official trial listing → -
Status unknown NCT NCT04355858
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
Not yet reported Fudan University 319 participants Est. completion 2025-04-01 1 siteOther conditions: Breast Cancer, Metastatic CancerView official trial listing → -
Withdrawn NCT NCT04374279
Trial to Promote Recovery From COVID-19 With Endocrine Therapy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2022-01 1 siteOther conditions: COVID-19, SARS-CoV 2View official trial listing → -
Active, not recruiting NCT NCT04379570
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Not yet reported Alliance for Clinical Trials in Oncology 1167 participants Est. completion 2027-10-04 526 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2 Negative Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8View official trial listing → -
Active, not recruiting NCT NCT04383275
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Not yet reported Fudan University 367 participants Est. completion 2031-07-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04389424
Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer
Instituto Jalisciense de Cancerologia 300 participants Est. completion 2022-01-30 1 siteOther conditions: Breast Cancer, Endocrine Therapy, Endocrine Therapy Adverse Reaction, Vitamin D Deficiency, Nutrition Disorders, ObesityView official trial listing → -
Status unknown NCT NCT04400942
Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy
Ospedale Policlinico San Martino 600 participants Est. completion 2021-12-01 1 siteOther conditions: Uterine Fibroids, Uterine MyomasView official trial listing → -
Status unknown NCT NCT04409691
SCMC Trial on KHE With KMP (V.2020)
Not yet reported Shanghai Children's Medical Center 20 participants Est. completion 2023-06-30 1 siteOther conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)View official trial listing → -
Completed NCT NCT04420481
Growth Hormone in Ischemic Heart Failure
Not yet reported Göteborg University 37 participants Est. completion 2012-02-25Heart failure Other conditions: Ischemic Heart Disease ChronicView official trial listing → -
Completed NCT NCT04420598
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
Not yet reported MedSIR 41 participants Est. completion 2023-04-04 16 sitesOther conditions: Advanced Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Leptomeningeal MetastasisView official trial listing → -
Completed NCT NCT04424108
Hormone Therapy on Serum Ischemia Modified Albumin in Menopausal Women
Karadeniz Technical University 30 participants Est. completion 2010-05-20Other conditions: Hormone Therapy Induced Morphologic Change, Surgical MenopauseView official trial listing → -
Completed NCT NCT04424173
Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women
Karadeniz Technical University 45 participants Est. completion 2008-08-30Other conditions: CRP, MenopauseView official trial listing → -
Active, not recruiting NCT NCT04446117
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
Not yet reported Exelixis 575 participants Est. completion 2026-10-16 280 sitesOther conditions: Metastatic Prostate Cancer, Prostate AdenocarcinomaView official trial listing → -
Status unknown NCT NCT04453332
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 siteOther conditions: Menopause, Hormone Replacement TherapyView official trial listing → -
Completed NCT NCT04459650
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2025-08-14 1 siteOther conditions: AlopeciaView official trial listing → -
Completed NCT NCT04460898
RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.
Pfizer 195 participants Est. completion 2019-06-24 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04465097
Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer
Not yet reported First Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2023-10-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04478760
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
King's College Hospital NHS Trust 250 participants Est. completion 2024-05-14 1 siteOther conditions: Transgender Persons, Hormone Replacement Therapy, Reference ValuesView official trial listing → -
Active, not recruiting NCT NCT04484818
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Not yet reported ECOG-ACRIN Cancer Research Group 27 participants Est. completion 2028-05-31 115 sitesOther conditions: Prostate CarcinomaView official trial listing → -
Status unknown NCT NCT04498793
Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55 participants Est. completion 2022-12 2 sitesOther conditions: HER2-negative Breast CancerView official trial listing → -
Status unknown NCT NCT04501003
Investigation of U1-A Uterine Anomalies Implantation Markers From the Lateral Walls of the Endometrium
Not yet reported Ufuk University 35 participants Est. completion 2021-05 1 siteOther conditions: T-Shaped Uterus, Infertility, Female, Genital Tract AnomaliesView official trial listing → -
Terminated NCT NCT04515472
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2025-03-17 1 siteOther conditions: Transgender PersonsView official trial listing → -
Completed NCT NCT04515888
Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 246 participants Est. completion 2021-07-06 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT04524325
Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone
Not yet reported Yale University Est. completion 2024-06-30Other conditions: Transgender Men, Blood Pressure, HyperandrogenismView official trial listing → -
Completed NCT NCT04524728
Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy
Istituti Clinici Scientifici Maugeri SpA 191 participants Est. completion 2020-06 1 siteOther conditions: Breast, Neoplasm Malignant, FemaleView official trial listing → -
Completed NCT NCT04531943
Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women
Emory University 285 participants Est. completion 2024-04-04 1 siteOther conditions: HIV PreventionView official trial listing → -
Status unknown NCT NCT04539496
A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
Not yet reported, Not yet reported Sihuan Pharmaceutical Holdings Group Ltd. 402 participants Est. completion 2025-12-31 1 siteOther conditions: Metastasis Solid Tumors, Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04554927
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
Not yet reported Centre Francois Baclesse 438 participants Est. completion 2026-12-31 1 siteOther conditions: Web-application, Breast Cancer, Hormono TherapyView official trial listing → -
Active, not recruiting NCT NCT04565054
Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC
Not yet reported Women's Cancer Study Group GmbH 1260 participants Est. completion 2029-07 85 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT04567446
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
Gustave Roussy, Cancer Campus, Grand Paris 1100 participants Est. completion 2024-12 9 sitesOther conditions: CancerView official trial listing → -
Terminated NCT NCT04578106
Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
Not yet reported Fundacio Clinic Barcelona 5 participants Est. completion 2024-07-16 1 siteOther conditions: HER2-positive Breast Cancer, Stage I Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04584853
PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
Not yet reported Institute of Cancer Research, United Kingdom 123 participants Est. completion 2030-10 62 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Active, not recruiting NCT NCT04590417
Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women
Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT04591548
Biomarkers in Endometriosis
University Medical Centre Ljubljana 100 participants Est. completion 2021-01-01Other conditions: EndometriosisView official trial listing → -
Active, not recruiting NCT NCT04593680
Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men
Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 siteOther conditions: Drug InteractionView official trial listing → -
Active, not recruiting NCT NCT04597580
Personalised Disease Monitoring in Metastatic Breast Cancer
The Christie NHS Foundation Trust 97 participants Est. completion 2030-01-31 7 sitesOther conditions: Breast Cancer Metastatic, Estrogen Receptor-positive Breast CancerView official trial listing → -
Completed NCT NCT04600336
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer
Not yet reported Alliance for Clinical Trials in Oncology 88 participants Est. completion 2024-03-11 103 sitesOther conditions: Prostate CarcinomaView official trial listing → -
Status unknown NCT NCT04646564
Radiotherapy for Extracranial Oligometastatic Breast Cancer
Not yet reported Chinese Academy of Medical Sciences 170 participants Est. completion 2026-04-30 2 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT04647474
Mental Wellbeing and Quality of Life in Prostate Cancer
King's College London 300 participants Est. completion 2023-03-29 7 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT04659551
Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients
Not yet reported Istituto Oncologico Veneto IRCCS 43 participants Est. completion 2020-05-25 5 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04666805
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04675814
Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA)
Institut Cancerologie de l'Ouest 37 participants Est. completion 2021-03-14 1 siteOther conditions: Sports Physical TherapyView official trial listing → -
Completed NCT NCT04676607
SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6 participants Est. completion 2023-06-12 1 siteOther conditions: Metastatic Castration-resistant Prostate CancerView official trial listing → -
Completed NCT NCT04681768
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Technical University of Munich 95 participants Est. completion 2025-04-01 1 siteOther conditions: Breast Cancer/ Metastatic Breast CancerView official trial listing → -
Suspended NCT NCT04684628
68Ga-PSMA PET/CT in Prostate Cancer
Not yet reported University of Saskatchewan 500 participants Est. completion 2025-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT04696250
Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR)
University Hospital, Caen 5000000 participants Est. completion 2025-01-01 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT04707196
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Not yet reported Eli Lilly and Company 200 participants Est. completion 2023-01-09 15 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Active, not recruiting NCT NCT04733118
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
Not yet reported MedSIR 393 participants Est. completion 2028-03 41 sitesOther conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT04735549
Vulvovaginal Atrophy Correction Using Neodymium Laser
Not yet reported MeLSyTech, Ltd 120 participants Est. completion 2023-10-20 1 siteOther conditions: Postmenopausal Period, Vaginal Atrophy, Female Urogenital DiseasesView official trial listing → -
Completed NCT NCT04736576
Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy
Not yet reported Pfizer 99 participants Est. completion 2023-03-24 20 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04736797
Transition in Transgender
RWTH Aachen University 200 participants Est. completion 2023-08-01 2 sitesOther conditions: Gender DysphoriaView official trial listing → -
Terminated NCT NCT04738292
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sitesOther conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic CancerView official trial listing → -
Completed NCT NCT04742491
Pre-Exposure Prophylaxis for Transgender Women in the US and South America
Not yet reported, Not yet reported HIV Prevention Trials Network 304 participants Est. completion 2024-08-16 5 sites Stand-aloneOther conditions: HIV PreventionView official trial listing → -
Terminated NCT NCT04752332
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Not yet reported Eli Lilly and Company 111 participants Est. completion 2024-06-26 115 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT04753177
The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Not yet reported, Not yet reported Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120 participants Est. completion 2024-01-28 1 siteOther conditions: The Neoadjuvant TherapyView official trial listing → -
Active, not recruiting NCT NCT04762979
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sitesOther conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04767594
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
Pfizer 1407 participants Est. completion 2028-04-30 192 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT04798976
Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer
Center of Personalized Medicine, Pirogova 3000 participants Est. completion 2021-05-30 1 siteOther conditions: Breast Cancer-specific SurvivalView official trial listing → -
Completed NCT NCT04812665
Digital Health for Caregivers Emotional and Self-management Support
Adhera Health, Inc. 65 participants Est. completion 2022-08-12 1 siteOther conditions: Emotional Adjustment, Mood DisturbanceView official trial listing → -
Status unknown NCT NCT04824339
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.
Not yet reported University of British Columbia 132 participants Est. completion 2023-12-31 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT04842617
Phase III Study :SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 5274 participants Est. completion 2031-10-31 1 siteOther conditions: Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast CancerView official trial listing → -
Status unknown NCT NCT04856371
Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer
Not yet reported Haihe Biopharma Co., Ltd. 228 participants Est. completion 2022-12Other conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT04861896
A Research Study for Latina Women With Breast Cancer
Not yet reported Northwestern University 58 participants Est. completion 2023-11-07 1 siteOther conditions: Cancer, Breast, Cancer-related Problem/Condition, Quality of Life, Hormone Dependent Neoplasms, Adherence, MedicationView official trial listing → -
Completed NCT NCT04864405
Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance
Not yet reported Ottawa Hospital Research Institute 245 participants Est. completion 2023-07-29 2 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04875351
Breast Cancer Index (BCI) Registry
Biotheranostics, Inc. 3465 participants Est. completion 2028-12 105 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04883398
A Study of Attention and Memory Processes in Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center 65 participants Est. completion 2027-05 1 siteOther conditions: Breast Cancer SurvivorsView official trial listing → -
Completed NCT NCT04887701
Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women
Not yet reported Madorra 25 participants Est. completion 2022-08-22 3 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT04892914
Embr Thermal Device for Hot Flash Management in Prostate Cancer
Not yet reported Embr Labs, Inc. 57 participants Est. completion 2021-12-05 1 siteOther conditions: Prostate Cancer, Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT04906395
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Not yet reported Tolmar Inc. 250 participants Est. completion 2027-01-30 59 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04915508
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
Not yet reported Jonsson Comprehensive Cancer Center 165 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT04922008
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)
Not yet reported Fudan University 356 participants Est. completion 2026-06-30Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04930055
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
Indiana University 2206 participants Est. completion 2022-03-08 2 sitesOther conditions: CancerView official trial listing → -
Completed NCT NCT04938466
Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
University of Minnesota 19 participants Est. completion 2024-10-30 1 siteOther conditions: Growth Hormone Deficiency, Growth Hormone TreatmentView official trial listing → -
Completed NCT NCT04943497
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Novartis Pharmaceuticals 2390 participants Est. completion 2025-07-28 57 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04961996
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 621 sitesOther conditions: Early Breast CancerView official trial listing → -
Status unknown NCT NCT04971447
Extracellular Vesicles and Endothelial Function in Transgender Subjects
Not yet reported Central Hospital, Nancy, France 136 participants Est. completion 2024-01Other conditions: TransgenderismView official trial listing → -
Status unknown NCT NCT04972448
RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer
Zhejiang Cancer Hospital 500 participants Est. completion 2025-11Other conditions: Breast Cancer, RecurrenceView official trial listing → -
Active, not recruiting NCT NCT04975308
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
Not yet reported Eli Lilly and Company 874 participants Est. completion 2027-08 243 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT04981275
A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
Onegevity Health 81 participants Est. completion 2023-09-30 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT04995731
Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer
Assiut University 328 participants Est. completion 2024-07 1 siteOther conditions: Endometrial CancerView official trial listing → -
Status unknown NCT NCT05000736
Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC
Chinese Academy of Medical Sciences 600 participants Est. completion 2022-09-01 1 siteOther conditions: Hormone Receptor Positive Advanced Breast CancerView official trial listing → -
Completed NCT NCT05010707
Transgender Estradiol Affirming Therapy
Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 siteOther conditions: TransgenderismView official trial listing → -
Status unknown NCT NCT05026073
Vibrational Spectroscopy for Endometrial Cancer Diagnosis
Nottingham University Hospitals NHS Trust 150 participants Est. completion 2024-11 1 siteOther conditions: Endometrial Cancer, Endometrial HyperplasiaView official trial listing → -
Active, not recruiting NCT NCT05041842
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
Not yet reported UNICANCER 53 participants Est. completion 2026-04-30 16 sitesOther conditions: Metastatic Breast Cancer With a Isolated Brain ProgressionView official trial listing → -
Completed NCT NCT05043506
European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies
Pfizer 1939 participants Est. completion 2023-11-02 64 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05050981
Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life
Faculdade de Medicina do ABC 74 participants Est. completion 2022-02-28 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT05054751
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported Genor Biopharma Co., Ltd. 275 participants Est. completion 2024-03-30 54 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05070234
Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
Chunxiu Gong 150 participants Est. completion 2022-08-30Other conditions: Small for Gestational Age Infant, Silver-Russell Syndrome, Genetic Diseases, InbornView official trial listing → -
Completed NCT NCT05072756
Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits
Faculdade de Medicina do ABC 1339 participants Est. completion 2021-09-04 1 siteOther conditions: Menopause, Opinions, Hormone Replacement TherapyView official trial listing → -
Terminated NCT NCT05084859
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Not yet reported Biosplice Therapeutics, Inc. 30 participants Est. completion 2022-10-20 20 sitesOther conditions: Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal CancerView official trial listing → -
Completed NCT NCT05085678
Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy
Not yet reported Universitaire Ziekenhuizen KU Leuven 77 participants Est. completion 2022-12-31 1 siteOther conditions: Breast Cancer, Quality of Life, Self EfficacyView official trial listing → -
Active, not recruiting NCT NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 50 participants Est. completion 2027-10-19 7 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT05110391
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
ANDROFERT - Clinica de Andrologia e Reproducao Humana 616 participants Est. completion 2021-09-15 1 siteOther conditions: Non-obstructive Azoospermia, Hormone Deficiency, Hypogonadism, Male, Male InfertilityView official trial listing → -
Completed NCT NCT05122377
RWE About QOL and Compliance of Patients With OFS in China
Fudan University 562 participants Est. completion 2025-05-01 1 siteOther conditions: Breast Cancer, Quality of Life, Hormone Receptor-positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05131893
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary 300 participants Est. completion 2031-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05138510
Sexual Health in Breast Cancer Patients
University of Colorado, Denver 93 participants Est. completion 2025-10-23 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05150652
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
Not yet reported Irada Ibrahim-zada 8 participants Est. completion 2026-06-10 1 siteOther conditions: Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer, Breast CarcinomaView official trial listing → -
Status unknown NCT NCT05156814
Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women
Not yet reported Scientific Research Institute of Public Health, Russian Federation 150 participants Est. completion 2023-05 1 siteOther conditions: Perimenopausal Disorder, Hot FlashesView official trial listing → -
Completed NCT NCT05159778
Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)
Not yet reported HiberCell, Inc. 26 participants Est. completion 2023-04-12 16 sitesOther conditions: Malignant Neoplasm of BreastView official trial listing → -
Terminated NCT NCT05176080
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Not yet reported, Not yet reported Henan Cancer Hospital 46 participants Est. completion 2024-07-03 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05186545
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sitesOther conditions: Breast Cancer, Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05195437
Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
Assistance Publique - Hôpitaux de Paris 36 participants Est. completion 2024-10-12 1 siteOther conditions: Growth Hormone TreatmentView official trial listing → -
Active, not recruiting NCT NCT05204927
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Not yet reported Curium US LLC 439 participants Est. completion 2029-02 52 sitesOther conditions: Metastasis From Malignant Tumor of ProstateView official trial listing → -
Status unknown NCT NCT05205200
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Not yet reported Fudan University 338 participants Est. completion 2026-08-01 1 siteOther conditions: Breast Cancer, Metastatic CancerView official trial listing → -
Terminated NCT NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05238467
Immunological Responses of COVID-19 Vaccination
University Hospitals Cleveland Medical Center 42 participants Est. completion 2023-02-13 1 siteOther conditions: Cancer; ChemotherapyView official trial listing → -
Active, not recruiting NCT NCT05251714
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
Not yet reported, Not yet reported Treadwell Therapeutics, Inc 44 participants Est. completion 2026-08 4 sitesOther conditions: Advanced Solid Tumor, Breast CancerView official trial listing → -
Status unknown NCT NCT05264649
Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer
Not yet reported Show Chwan Memorial Hospital 72 participants Est. completion 2023-03-03 1 siteOther conditions: ArthralgiaView official trial listing → -
Status unknown NCT NCT05277935
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
Not yet reported Beneficência Portuguesa de São Paulo 68 participants Est. completion 2025-03-01 4 sitesOther conditions: Breast Neoplasm Female, Quality of LifeView official trial listing → -
Status unknown NCT NCT05279118
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
Not yet reported, Not yet reported All India Institute of Medical Sciences 80 participants Est. completion 2024-07-28 2 sitesOther conditions: Ketogenic Diet, West Syndrome, Infantile Spasm, ACTHView official trial listing → -
Not yet recruiting NCT NCT05285332
Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy
Not yet reported Changhai Hospital 362 participants Est. completion 2031-05-01Other conditions: Breast Neoplasms, Treatment, Metastatic Breast Cancer, SurvivalView official trial listing → -
Completed NCT NCT05324020
eHealth Intervention for Medication Adherence in Breast Cancer Survivors
Not yet reported Luxembourg Institute of Health 3 participants Est. completion 2022-11-30 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05343117
Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC
Chinese Academy of Medical Sciences 400 participants Est. completion 2024-06-01 9 sitesOther conditions: Hormone Receptor Positive Advanced Breast CancerView official trial listing → -
Completed NCT NCT05346445
Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome
Not yet reported Hospital Regional 1o de Octubre 91 participants Est. completion 2021-12-20 1 siteOther conditions: Postmenopause, Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sitesOther conditions: Neoplasm, Breast, Congenital, Familial and Genetic DisordersView official trial listing → -
Completed NCT NCT05392985
Detection and Analysis of MBC With Heterogeneous ER Expression
Fudan University 51 participants Est. completion 2022-12-15 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05411380
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.
Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05415930
Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 100 participants Est. completion 2025-02-28Other conditions: TransgenderismView official trial listing → -
Status unknown NCT NCT05433480
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer
Not yet reported Betta Pharmaceuticals Co., Ltd. 274 participants Est. completion 2025-07-31 64 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05437679
Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System
Angle plc 9 participants Est. completion 2023-08-22 2 sitesOther conditions: High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, Prostate CancerView official trial listing → -
Status unknown NCT NCT05452213
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Not yet reported Institut fuer Frauengesundheit 1000 participants Est. completion 2026-10 52 sitesOther conditions: Breast Cancer, Breast Neoplasms, Breast Neoplasm Female, Breast Cancer Female, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05460819
Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-07-31 1 siteOther conditions: Hot Flashes, Breast Cancer, AcupunctureView official trial listing → -
Completed NCT NCT05465408
Culturally Aware AET Non-Initiation Intervention
Not yet reported Massachusetts General Hospital 35 participants Est. completion 2024-11-20 11 sitesOther conditions: Breast Cancer, Survivorship, Treatment Compliance, Treatment Adherence, Treatment RefusalView official trial listing → -
Completed NCT NCT05469204
Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 siteOther conditions: Transgender PersonsView official trial listing → -
Completed NCT NCT05483621
Hormonal Stimulation of Spermatogenesis
Not yet reported Egymedicalpedia 100 participants Est. completion 2022-03-01 1 site Stand-aloneOther conditions: Azoospermia, NonobstructiveView official trial listing → -
Active, not recruiting NCT NCT05486182
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
Not yet reported GE Healthcare 153 participants Est. completion 2026-01 11 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05488145
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy
Not yet reported Emory University 21 participants Est. completion 2025-12-10 4 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT05503160
Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application
Not yet reported Technical University of Munich 400 participants Est. completion 2026-06 1 siteOther conditions: New Healthcare ApproachView official trial listing → -
Status unknown NCT NCT05504213
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 224 participants Est. completion 2025-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05512416
Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer
Not yet reported The Affiliated Hospital of Qingdao University 35 participants Est. completion 2024-05Other conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05514054
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Not yet reported Eli Lilly and Company 8000 participants Est. completion 2032-03 672 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT05525481
Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
Not yet reported Erasmus Medical Center 100 participants Est. completion 2024-02-28 1 siteOther conditions: ER+ Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05529862
Trans-RosaLEE Study: a Biomarker-directed, Translational Study
Not yet reported Institut Paoli-Calmettes 115 participants Est. completion 2028-11-01 1 siteOther conditions: Advanced or Metastatic Breast Cancer (BC)View official trial listing → -
Completed NCT NCT05544227
Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer
Not yet reported Williams Cancer Foundation 15 participants Est. completion 2025-06-01 1 siteOther conditions: Metastatic Castration-resistant Prostate CancerView official trial listing → -
Status unknown NCT NCT05550090
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
Zhejiang Cancer Hospital 40 participants Est. completion 2025-12-30 1 siteOther conditions: Metastatic Breast Cancer in the LiverView official trial listing → -
Completed NCT NCT05562518
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
Not yet reported University Hospital, Ghent 31 participants Est. completion 2026-03-02 1 siteOther conditions: Vulvovaginal Atrophy, Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05568472
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Not yet reported SWOG Cancer Research Network 565 participants Est. completion 2028-05-01 490 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Withdrawn NCT NCT05568940
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2026-04 1 siteOther conditions: Endometriosis, FibroidsView official trial listing → -
Active, not recruiting NCT NCT05569811
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial
Not yet reported SOLTI Breast Cancer Research Group 120 participants Est. completion 2030-07-31 25 sitesOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05583058
Sex Hormone Overdose and Misuse in Chinese Transgender and Gender Non-conforming Population
Xiamen University 260 participants Est. completion 2029-03-30 1 siteOther conditions: Gender Incongruence, Gender DysphoriaView official trial listing → -
Active, not recruiting NCT NCT05587296
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Not yet reported Bayer 474 participants Est. completion 2028-06-05 102 sitesOther conditions: Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT05607004
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Not yet reported Atossa Therapeutics, Inc. 87 participants Est. completion 2027-04 14 sitesOther conditions: Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05612100
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
Mayo Clinic 169 participants Est. completion 2028-07-09 23 sitesOther conditions: Breast CarcinomaView official trial listing → -
Not yet recruiting NCT NCT05613504
Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-12-01 1 siteOther conditions: Hot Flashes, Breast Cancer, AcupunctureView official trial listing → -
Terminated NCT NCT05617885
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
Not yet reported Praful Ravi, MB BCHir, MRCP 9 participants Est. completion 2026-06-01 1 site Stand-aloneOther conditions: Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate CancerView official trial listing → -
Status unknown NCT NCT05640778
Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2025-10-31 1 siteOther conditions: Luminal B/HER2-negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05643131
Hyivy Device as Non-hormonal Therapy in Endometriosis
Not yet reported Hyivy Health Inc 20 participants Est. completion 2026-12 1 siteOther conditions: Endometriosis, Pelvic PainView official trial listing → -
Enrolling by invitation NCT NCT05645536
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Not yet reported Tolmar Inc. 250 participants Est. completion 2030-03 46 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
Not yet reported Maple Leaf Research 45 participants Est. completion 2025-01 1 siteOther conditions: Hiv, TransgenderismView official trial listing → -
Withdrawn NCT NCT05664893
Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)
Not yet reported, Not yet reported Centre Antoine Lacassagne Est. completion 2026-03-26 1 siteOther conditions: HER2 Negative Breast Cancer Not Immediately OperatedView official trial listing → -
Active, not recruiting NCT NCT05669664
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2026-11-30 27 sitesOther conditions: Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Unresectable Salivary Gland CarcinomaView official trial listing → -
Completed NCT NCT05678192
Effect of Menopausal Hormone Therapy on Immune System Parameters
Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 siteOther conditions: Last Period Not Earlier Than 6 Months AgoView official trial listing → -
Status unknown NCT NCT05680194
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients
Peking Union Medical College Hospital 1000 participants Est. completion 2025-12-01 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05690295
Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer
Not yet reported Universidad de La Frontera 26 participants Est. completion 2024-05-15 1 siteOther conditions: Breast Cancer Survivors, Postmenopause, Resistance TrainingView official trial listing → -
Active, not recruiting NCT NCT05697146
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France
Novartis Pharmaceuticals 1019 participants Est. completion 2028-06-30 82 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05700006
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
University of Michigan 94 participants Est. completion 2026-02-26 1 siteOther conditions: Breast Neoplasm Female, Arthralgia, AgingView official trial listing → -
Status unknown NCT NCT05717634
Endometrial Changes in Breast Cancer Women.
Regina Elena Cancer Institute 829 participants Est. completion 2024-01-26 1 siteOther conditions: Endometrial Cancer, Endometrial Hyperplasia With Atypia, Breast Cancer, TAMView official trial listing → -
Active, not recruiting NCT NCT05730647
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
Consorzio Oncotech 600 participants Est. completion 2032-07-31 40 sitesOther conditions: Early Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05754528
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Not yet reported Ottawa Hospital Research Institute 240 participants Est. completion 2030-02 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05755581
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Not yet reported Sohag University 100 participants Est. completion 2025-08-01 1 siteOther conditions: Female Breast CancerView official trial listing → -
Status unknown NCT NCT05766410
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
Not yet reported National Taiwan University Hospital 60 participants Est. completion 2026-09-30 2 sitesOther conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone TherapyView official trial listing → -
Active, not recruiting NCT NCT05780567
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1946 participants Est. completion 2027-01 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05789771
Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.
Blokhin's Russian Cancer Research Center 136 participants Est. completion 2022-12-01 1 siteOther conditions: HR+/HER2- Breast Cancer, Metastatic Disease, Аdvanced DiseaseView official trial listing → -
Status unknown NCT NCT05800197
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 siteOther conditions: Breast Cancer, Neoadjuvant Endocrine TherapyView official trial listing → -
Active, not recruiting NCT NCT05827081
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Not yet reported Novartis Pharmaceuticals 1466 participants Est. completion 2030-09-20 214 sitesOther conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT05865262
Protocol TRANS and QT Repolarization
University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 siteOther conditions: Transgender Individuals, QTc IntervalView official trial listing → -
Active, not recruiting NCT NCT05870579
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2032-05-27 13 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05887102
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Not yet reported CHU de Quebec-Universite Laval 66 participants Est. completion 2025-03 1 siteOther conditions: Breast Neoplasms, Breast CancerView official trial listing → -
Completed NCT NCT05887297
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Not yet reported University of Strathclyde 35 participants Est. completion 2024-04-23 1 siteOther conditions: Insomnia, Breast Cancer, Adherence, Medication, Quality of Life, SurvivorshipView official trial listing → -
Status unknown NCT NCT05889871
A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer
Not yet reported Fudan University 916 participants Est. completion 2026-06-01Other conditions: HR+/HER2-breast CancerView official trial listing → -
Status unknown NCT NCT05890287
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 siteOther conditions: HR Positive HER2 Negative Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05891795
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Not yet reported, Not yet reported Stanford University 18 participants Est. completion 2026-06 1 siteOther conditions: Acne VulgarisView official trial listing → -
Terminated NCT NCT05894876
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Novo Nordisk A/S 43 participants Est. completion 2025-03-21 4 sitesOther conditions: Idiopathic Short StatureView official trial listing → -
Completed NCT NCT05894954
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sitesOther conditions: Mild Cognitive Impairment, Dementia, MildView official trial listing → -
Completed NCT NCT05896605
Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder
Not yet reported First Affiliated Hospital of Guangxi Medical University 63 participants Est. completion 2023-04-01 1 siteOther conditions: NMO Spectrum Disorder, Azathioprine Adverse ReactionView official trial listing → -
Active, not recruiting NCT NCT05914792
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery
University of Pittsburgh 49 participants Est. completion 2026-07-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05927779
Study of TFX06 in Women With Advanced Breast Cancer.
Not yet reported, Not yet reported Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 74 participants Est. completion 2025-04-30 2 sitesOther conditions: ER+, HER2- Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05934877
ASK-PrEP (Assistance Services Knowledge-PrEP)
Not yet reported Friends Research Institute, Inc. 152 participants Est. completion 2025-03-19 1 siteSubstance use disorder Other conditions: HIVView official trial listing → -
Active, not recruiting NCT NCT05952557
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Not yet reported AstraZeneca 5511 participants Est. completion 2037-05-06 661 sitesOther conditions: Breast Cancer, Early Breast CancerView official trial listing → -
Terminated NCT NCT05966584
A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2024-08-02 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05969184
Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC
Not yet reported Peking University Cancer Hospital & Institute 94 participants Est. completion 2026-06-25 2 sitesOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT05979480
The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study)
University Hospital Birmingham 25 participants Est. completion 2025-11-30 1 siteOther conditions: Adult Growth Hormone DeficiencyView official trial listing → -
Status unknown NCT NCT05982470
Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI
Not yet reported Beijing Tiantan Hospital 328 participants Est. completion 2025-10-01 1 siteOther conditions: Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment, White Matter HyperintensityView official trial listing → -
Not yet recruiting NCT NCT05986071
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers
Not yet reported, Not yet reported Institut Paoli-Calmettes 57 participants Est. completion 2027-10-15 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06001762
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sitesOther conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast CarcinomaView official trial listing → -
Completed NCT NCT06009627
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Not yet reported, Not yet reported Tianjin Medical University Cancer Institute and Hospital 119 participants Est. completion 2025-09-11 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06016738
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Not yet reported Olema Pharmaceuticals, Inc. 510 participants Est. completion 2028-02-29 233 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT06018337
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
Not yet reported DualityBio Inc. 541 participants Est. completion 2028-08 258 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06027541
Young Patients With Early Breast Cancer
Peking Union Medical College Hospital 1000 participants Est. completion 2028-02-01 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT06040593
Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
Daiichi Sankyo 927 participants Est. completion 2024-02-23 1 siteOther conditions: Hormone-receptor-positive Breast Cancer, HER2-low Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Completed NCT NCT06049797
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Astellas Pharma Global Development, Inc. 999 participants Est. completion 2026-05-07 48 sitesOther conditions: Hot FlashesView official trial listing → -
Status unknown NCT NCT06061666
Treatment of Insomnia in Patients With Breast Cancer
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80 participants Est. completion 2024-06-30 1 siteOther conditions: Breast Cancer, InsomniaView official trial listing → -
Completed NCT NCT06064851
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease
Not yet reported Five Liters, Inc. 29 participants Est. completion 2025-04-18 1 site Stand-aloneOther conditions: Von Willebrand Disease, Type 1, Heavy Menstrual BleedingView official trial listing → -
Active, not recruiting NCT NCT06065748
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast CancerView official trial listing → -
Completed NCT NCT06072196
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer 3017 participants Est. completion 2024-12-18 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT06075758
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 175 participants Est. completion 2025-06-30 3 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06080620
The Choice of Treatment Methods and Efficacy of LABC
Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2026-08-01 1 siteOther conditions: Locally Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06105632
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Not yet reported Pfizer 333 participants Est. completion 2028-01-21 48 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06116201
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
Not yet reported Chulalongkorn University 60 participants Est. completion 2021-07-31 1 siteOther conditions: Transgender WomenView official trial listing → -
Terminated NCT NCT06126003
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
BioCorteX Inc 2 participants Est. completion 2024-07-31 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06131424
NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
AstraZeneca 1151 participants Est. completion 2025-05-19 31 sitesOther conditions: HER2-negativeView official trial listing → -
Completed NCT NCT06133465
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management
Istituto Oncologico Veneto IRCCS 1063 participants Est. completion 2025-01-31 1 siteOther conditions: Pleomorphic Lobular Breast Carcinoma in Situ, Breast Florid Lobular Carcinoma in SituView official trial listing → -
Active, not recruiting NCT NCT06148506
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
Novartis Pharmaceuticals 376 participants Est. completion 2027-06-30 20 sitesOther conditions: HR+HER2- Advanced Breast CancerView official trial listing → -
Completed NCT NCT06149065
Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
Mahidol University 247 participants Est. completion 2023-06-06 1 siteOther conditions: Acne, TransgenderismView official trial listing → -
Completed NCT NCT06151418
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Pfizer 2313 participants Est. completion 2024-04-23 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Status unknown NCT NCT06154590
Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
DR. DIANE CHISESI NFS. MD. PHD. 100 participants Est. completion 2026-09 1 siteOther conditions: Metastatic Breast Cancer, Tumor, Muscle Neoplasms, Chronic PainView official trial listing → -
Completed NCT NCT06168890
Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.
IRCCS San Raffaele 195 participants Est. completion 2014-02-25Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT06172088
Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy
Not yet reported University Hospital Tuebingen 54 participants Est. completion 2025-09-30 2 sitesOther conditions: Breast Cancer Patients Treated With Aromatase InhibitorsView official trial listing → -
Status unknown NCT NCT06192446
Factors Influencing Adherence to Adjuvant Endocrine Therapy
University of Zagreb 1000 participants Est. completion 2024-09-20 1 siteOther conditions: Adherence, TreatmentView official trial listing → -
Status unknown NCT NCT06195202
Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)
Sun Yat-sen University 2000 participants Est. completion 2026-08-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06201897
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
Not yet reported, Not yet reported All India Institute of Medical Sciences 40 participants Est. completion 2026-06 1 siteOther conditions: West SyndromeView official trial listing → -
Not yet recruiting NCT NCT06223698
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
Not yet reported Region Örebro County 3832 participants Est. completion 2035-05-02 15 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06229366
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
Not yet reported Eli Lilly and Company 142 participants Est. completion 2032-12 7 sitesOther conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma, Hormone Sensitive Prostate CancerView official trial listing → -
Completed NCT NCT06246084
INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
Not yet reported Dana-Farber Cancer Institute 76 participants Est. completion 2024-12-23 1 siteOther conditions: Breast Cancer, Breast Cancer Female, Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT06247995
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
Not yet reported, Not yet reported Novartis Pharmaceuticals 20 participants Est. completion 2027-04-14 28 sitesOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06306404
Sleeping Through Menopause
Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01Other conditions: Menopause, InsomniaView official trial listing → -
Completed NCT NCT06311383
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment
Novartis Pharmaceuticals 2610 participants Est. completion 2025-03-10 265 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06338644
Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.
Helwan University 100 participants Est. completion 2026-09-01Other conditions: Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06343987
The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
Not yet reported Aarhus University Hospital 21 participants Est. completion 2025-04-24 1 siteOther conditions: Metastatic Breast Cancer, Estrogen-receptor-positive Breast Cancer, AdiposityView official trial listing → -
Completed NCT NCT06344793
Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
Fudan University 608 participants Est. completion 2025-02-01 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06355401
Maintenance Hormonal Therapy and DLBCL
Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2029-03Other conditions: Diffuse Large B Cell LymphomaView official trial listing → -
Status unknown NCT NCT06369909
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Peking Union Medical College Hospital 180 participants Est. completion 2026-01-31 1 siteOther conditions: Autoimmune PancreatitisView official trial listing → -
Completed NCT NCT06375707
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06379659
Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer
Not yet reported, Not yet reported Isfahan University of Medical Sciences 54 participants Est. completion 2024-09-14 1 siteOther conditions: Thin Endometrium, Infertility Female, InfertilityView official trial listing → -
Completed NCT NCT06388304
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence
Not yet reported Joanna Arch 39 participants Est. completion 2025-04-18 1 siteOther conditions: Breast Cancer, DCISView official trial listing → -
Not yet recruiting NCT NCT06407401
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 399 participants Est. completion 2028-11-30Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Drug-Related Side Effects and Adverse Reactions, Musculoskeletal PainView official trial listing → -
Terminated NCT NCT06408168
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 siteOther conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular CarcinomaView official trial listing → -
Status unknown NCT NCT06415162
Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality
Not yet reported Saglik Bilimleri Universitesi 64 participants Est. completion 2024-07-31 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06428396
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06440967
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sitesOther conditions: Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT06447623
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 siteOther conditions: Advanced Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT06448195
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery
Not yet reported Shanghai Zhongshan Hospital 40 participants Est. completion 2025-12-31 1 siteOther conditions: Growth Hormone TreatmentView official trial listing → -
Status unknown NCT NCT06455956
Use of miRNAs in Growth Hormone Deficiency (GHD)
University of Parma 400 participants Est. completion 2026-03-01 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Status unknown NCT NCT06458764
Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
Candiolo Cancer Institute - IRCCS 150 participants Est. completion 2025-12-01 1 siteOther conditions: Breast Cancer Female, Sexual Dysfunction, Premenopausal Breast CancerView official trial listing → -
Completed NCT NCT06464341
Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study
University Hospital, Basel, Switzerland 583 participants Est. completion 2024-12-31 62 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06470672
Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer
Not yet reported Fudan University 32 participants Est. completion 2026-07 1 siteOther conditions: Advanced Breast Cancer, Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Enrolling by invitation NCT NCT06472765
Vaginal Ecosystem and Network in the United States Study
Vaginal Biome Science 3250 participants Est. completion 2028-05-15 21 sitesOther conditions: Bacterial Vaginosis, Candidiasis, Urinary Tract Infections, Genitourinary Syndrome of Menopause, Lichen Sclerosus, Lichen Planus, Vulvodynia, Endometriosis, Ureaplasma Infections, Cancer, Desquamative Inflammatory VaginitisView official trial listing → -
Status unknown NCT NCT06481553
RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 480 participants Est. completion 2024-07-31 1 siteOther conditions: Breast Cancer Stage IVView official trial listing → -
Enrolling by invitation NCT NCT06481956
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Not yet reported Zheng Yabing 40 participants Est. completion 2027-10-10 1 siteOther conditions: HER2-positive Advanced Breast CancerView official trial listing → -
Completed NCT NCT06482385
Transmasculine Quality of Life and Sexual Function at Pre and Post Gender-affirming Hormonal Therapy
Chulalongkorn University 40 participants Est. completion 2024-05-31 1 siteOther conditions: Transgender MenView official trial listing → -
Active, not recruiting NCT NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Not yet reported Stemline Therapeutics, Inc. 4556 participants Est. completion 2032-10 555 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06494150
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 siteOther conditions: Low Grade Ovarian Serous AdenocarcinomaView official trial listing → -
Completed NCT NCT06500741
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
Astellas Pharma Global Development, Inc. 374 participants Est. completion 2025-04-02 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT06504953
Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy
Not yet reported Centre Hospitalier Universitaire de Nice 72 participants Est. completion 2026-06-17 1 siteOther conditions: Women, Tibial Translation, HormoneView official trial listing → -
Status unknown NCT NCT06505278
The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy
Not yet reported Sun Yat-sen University 70 participants Est. completion 2025-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT06508788
Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients
Hospital Universitari de Bellvitge 30 participants Est. completion 2026-07-01 1 siteOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Status unknown NCT NCT06510647
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
University of Cagliari 247 participants Est. completion 2026-05-31 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT06538818
Ultra Phonophoresis With a Hyaluronic Acid-Containing Gel on Carpal Tunnel Syndrome Post Mastectomy.
Not yet reported Cairo University 60 participants Est. completion 2024-11-01 1 siteOther conditions: Mastectomy, Carpal Tunnel Syndrome (CTS)View official trial listing → -
Status unknown NCT NCT06544577
Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
SciClone Pharmaceuticals 350 participants Est. completion 2026-08-01 1 siteOther conditions: ESR1 Gene Mutation, Advanced Breast Cancer, SafetyView official trial listing → -
Not yet recruiting NCT NCT06556862
Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor
Not yet reported Beijing 302 Hospital 155 participants Est. completion 2028-12-31 1 siteOther conditions: HR+/HER2- Advanced Breast CancerView official trial listing → -
Completed NCT NCT06570031
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
Not yet reported Ono Pharmaceutical Co., Ltd. 46 participants Est. completion 2026-04-30 13 sitesOther conditions: Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06583460
Systematic Intervention to Improve Sexual Dysfunction
Not yet reported Center Eugene Marquis 60 participants Est. completion 2028-06-09 1 siteOther conditions: Breast Cancer Female, Localized CancerView official trial listing → -
Withdrawn NCT NCT06585969
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
Not yet reported Danish Breast Cancer Cooperative Group Est. completion 2026-01-01Other conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal LikeView official trial listing → -
Active, not recruiting NCT NCT06599216
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
Not yet reported Harbin Medical University 30 participants Est. completion 2027-09-01 2 sitesOther conditions: Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Completed NCT NCT06603805
Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study
West China Hospital 974 participants Est. completion 2024-01-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06611514
Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer
Not yet reported European Institute of Oncology 95 participants Est. completion 2027-01-01 1 siteOther conditions: Women With Breast CancerView official trial listing → -
Terminated NCT NCT06617455
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial
Not yet reported University of Michigan Rogel Cancer Center 9 participants Est. completion 2025-11-21 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ, Localized Breast CarcinomaView official trial listing → -
Status unknown NCT NCT06621459
Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
University Hospital, Brest 30 participants Est. completion 2025-10-31 1 siteOther conditions: Brest Cancer, Abemaciclib, Adjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols, Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT06623903
Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
Aarhus University Hospital 112 participants Est. completion 2025-07-31 1 siteOther conditions: Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast CancerView official trial listing → -
Status unknown NCT NCT06642948
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
Not yet reported Fudan University 80 participants Est. completion 2025-01-01 1 siteOther conditions: Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase InhibitorsView official trial listing → -
Enrolling by invitation NCT NCT06650748
Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Not yet reported Peking University 100 participants Est. completion 2028-04-01 1 siteOther conditions: Breast Cancer, Early-stage Breast CancerView official trial listing → -
Completed NCT NCT06655545
18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
Fudan University 473 participants Est. completion 2025-02-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06656624
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
Not yet reported The First Affiliated Hospital with Nanjing Medical University 190 participants Est. completion 2025-12-31 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06662864
Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer
Institut Rafael 60 participants Est. completion 2023-12-31 1 siteOther conditions: Breast CancersView official trial listing → -
Active, not recruiting NCT NCT06668805
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Not yet reported BioMarin Pharmaceutical 30 participants Est. completion 2041-09 38 sitesOther conditions: Noonan SyndromeView official trial listing → -
Not yet recruiting NCT NCT06669273
Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)
Not yet reported University Hospital, Clermont-Ferrand 70 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Suspected Prostate Cancer (increased PSA Level)View official trial listing → -
Suspended NCT NCT06671912
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial
Not yet reported Alliance for Clinical Trials in Oncology 1556 participants Est. completion 2031-11-30 732 sitesOther conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In SituView official trial listing → -
Completed NCT NCT06690489
An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)
Pierre Fabre Medicament 155 participants Est. completion 2025-11-26 9 sitesOther conditions: Early Breast Cancer, Skin Condition, Quality of LifeView official trial listing → -
Active, not recruiting NCT NCT06702618
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2026-12 13 sitesOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06711094
Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC
Not yet reported Fujian Medical University 52 participants Est. completion 2028-12-30Other conditions: HR+/HER2- Advanced Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT06733415
Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy
Tel-Aviv Sourasky Medical Center 40 participants Est. completion 2026-12-31 1 siteOther conditions: Transgender, Transgender Persons, M01.777.500View official trial listing → -
Not yet recruiting NCT NCT06746376
Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.
Not yet reported Universidad Europea de Madrid 32 participants Est. completion 2025-11-01 1 siteOther conditions: ArthralgiaView official trial listing → -
Active, not recruiting NCT NCT06754293
Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol
Not yet reported Fudan University 24 participants Est. completion 2025-02-01 1 siteOther conditions: Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase InhibitorsView official trial listing → -
Active, not recruiting NCT NCT06760637
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Not yet reported Pfizer 1035 participants Est. completion 2037-12-29 460 sitesOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06763094
Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding
Not yet reported University of Health Sciences Lahore 100 participants Est. completion 2025-12Other conditions: Menorrhagia, Abnormal Uterine BleedingView official trial listing → -
Enrolling by invitation NCT NCT06765707
Symptom Monitoring Using Patient-Report to Improve Medication Use
Not yet reported Medical College of Wisconsin 225 participants Est. completion 2029-08 4 sitesOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Endocrine TherapyView official trial listing → -
Not yet recruiting NCT NCT06787118
Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 130 participants Est. completion 2027-05 1 siteOther conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, HR+ Breast Cancer, AI-related Musculoskeletal PainView official trial listing → -
Completed NCT NCT06806072
BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY
Not yet reported Parc de Salut Mar 84 participants Est. completion 2026-07-01 2 sitesOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Not yet recruiting NCT NCT06810492
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Not yet reported Hongmei Zheng, PhD 40 participants Est. completion 2027-12-01Other conditions: Breast Cancer Stage III, Breast Cancer Stage IIView official trial listing → -
Completed NCT NCT06830486
Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)
University of Colorado, Denver 40 participants Est. completion 2023-10-31 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06855589
Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.
Not yet reported Charles LeMoyne Hospital 400 participants Est. completion 2034-03 5 sitesOther conditions: Prostate Cancer (Adenocarcinoma)View official trial listing → -
Not yet recruiting NCT NCT06905886
Resting Energy Expenditure in Postmenopausal Women
Insel Gruppe AG, University Hospital Bern 37 participants Est. completion 2027-02 1 siteOther conditions: Postmenopause, Energy Expenditure, Hormone Replacement TherapyView official trial listing → -
Active, not recruiting NCT NCT06957379
Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78 participants Est. completion 2025-12 1 siteOther conditions: HR+/HER2- Advanced/Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06976593
Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors
University of Extremadura 30 participants Est. completion 2025-05-31 1 siteOther conditions: Breast Cancer Survivorship, Muscle Oxygenation, Near-infrared Spectroscopy, Exercise, Quality of Life, Functional Capacity, Hormonal TherapyView official trial listing → -
Completed NCT NCT07013422
The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer
Not yet reported Sultan Qaboos Comprehensive Cancer Center 58 participants Est. completion 2024-04-18 1 site Stand-aloneOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Not yet recruiting NCT NCT07028242
Ultrasound and Histology in AEH and Early EEC Treated Conservatively
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50 participants Est. completion 2027-06-30 1 siteOther conditions: Fertility-Sparing Treatment (FST), Atypical Endometrial Hyperplasia, Early Endometrial Cancer (EEC)View official trial listing → -
Not yet recruiting NCT NCT07061717
Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 474 participants Est. completion 2029-07-01 1 siteOther conditions: Hormone Receptor-Positive and HER2-Negative Advanced Breast CancerView official trial listing → -
Withdrawn NCT NCT07076680
A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer
SciClone Pharmaceuticals Est. completion 2027-07-01 1 siteOther conditions: Breast Cancer Metastatic, HR+/HER2- Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07078435
Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis
Not yet reported University Hospital, Grenoble 40 participants Est. completion 2027-09-30 1 siteOther conditions: Endometriosis, Immunity, MicrobiotaView official trial listing → -
Not yet recruiting NCT NCT07101159
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Not yet reported Fujian Cancer Hospital 200 participants Est. completion 2031-12Other conditions: Early Breast Cancer, Adjuvant Therapy, Hormone Receptor Positive / HER2-negative Breast CancerView official trial listing → -
Completed NCT NCT07103603
MHT and Liver Function in Postmenopausal Women
Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 siteOther conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic SteatosisView official trial listing → -
Enrolling by invitation NCT NCT07128771
Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
University Hospital, Akershus 450 participants Est. completion 2030-10 1 siteCardiovascular disease Other conditions: Gender IncongruenceView official trial listing → -
Active, not recruiting NCT NCT07130643
Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
Not yet reported Xinhong Wu, PhD 40 participants Est. completion 2027-06-20 1 siteOther conditions: HR+/HER2- Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07153757
De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial
Not yet reported Fudan University 2934 participants Est. completion 2033-09-01 1 siteOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Not yet recruiting NCT NCT07162259
Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer
Not yet reported Yan Xue 40 participants Est. completion 2027-12-31 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07164794
Memantine Hydrochloride in Prostate Cancer Patients
Not yet reported Bin Xu 15 participants Est. completion 2028-06Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)View official trial listing → -
Not yet recruiting NCT NCT07179939
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07180914
A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer
Zhejiang Cancer Hospital 300 participants Est. completion 2029-12-31Other conditions: Breast Cancer FemalesView official trial listing → -
Not yet recruiting NCT NCT07189884
Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy
Not yet reported, Not yet reported The First Affiliated Hospital of Xiamen University 33 participants Est. completion 2028-12-31Other conditions: Locally Advanced Breast Cancer (LABC)View official trial listing → -
Not yet recruiting NCT NCT07190651
Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50 participants Est. completion 2026-09-30Other conditions: Breast Cancer, CDK4/6 InhibitorView official trial listing → -
Completed NCT NCT07199556
Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.
Not yet reported Arafarma Group, S.A. 30 participants Est. completion 2025-09-10 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07213206
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer
Not yet reported Fudan University 1500 participants Est. completion 2035-09-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07235618
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 siteOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07245316
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
Not yet reported Jeong Eon Lee 340 participants Est. completion 2032-12-31 1 siteOther conditions: Ductal Carcinoma in Situ of the BreastView official trial listing → -
Not yet recruiting NCT NCT07269691
RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer
Not yet reported Pengfei Qiu 194 participants Est. completion 2027-12-01 1 siteOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07305246
Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer
Not yet reported First Hospital of China Medical University 120 participants Est. completion 2027-09Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07311122
Endocrine Therapy Base on 21-gene RS
Gangnam Severance Hospital 4000 participants Est. completion 2028-12-31Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07313202
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance
Not yet reported Fujian Cancer Hospital 72 participants Est. completion 2028-12-26Other conditions: Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAEView official trial listing → -
Completed NCT NCT07334626
Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy
Not yet reported Benha University 60 participants Est. completion 2026-07-20 1 siteOther conditions: Breast Cancer, Breast Cancer Survivors, Aromatase Inhibitors, Osteoporosis or Osteopenia, Pilates ExerciseView official trial listing → -
Completed NCT NCT07346287
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
Not yet reported Stratpharma AG 11 participants Est. completion 2026-02-19 1 site Stand-aloneOther conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)View official trial listing → -
Active, not recruiting NCT NCT07352748
Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
Universita di Verona 30 participants Est. completion 2026-10-17 1 siteOther conditions: Metastatic Prostate CancerView official trial listing → -
Not yet recruiting NCT NCT07358897
Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
Imperial College London 500 participants Est. completion 2029-01-07Other conditions: TransgenderView official trial listing → -
Completed NCT NCT07363434
A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib
Novartis Pharmaceuticals 335 participants Est. completion 2024-07-26 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT07368192
Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum
University of Castilla-La Mancha 492 participants Est. completion 2026-07-31 1 siteOther conditions: Cancer, NeoplamsView official trial listing → -
Not yet recruiting NCT NCT07368543
Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer
Not yet reported Fudan University 216 participants Est. completion 2028-12-01Other conditions: Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07376057
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150 participants Est. completion 2028-12-31 1 siteOther conditions: Prostatic Neoplasms, Castration-ResistantView official trial listing → -
Not yet recruiting NCT NCT07387861
PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study
Assiut University 70 participants Est. completion 2028-03Other conditions: Breast Cancer - ER+, HER2-, PIK3CA Gene MutationView official trial listing → -
Not yet recruiting NCT NCT07389174
Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Not yet reported Shanghai Changzheng Hospital 40 participants Est. completion 2027-06 1 siteOther conditions: mHSPC, mHNPC, Prostate Cancer AdenocarcinomaView official trial listing → -
Not yet recruiting NCT NCT07394049
A Prospective Multicenter Cohort Study of Contemporary Menopausal Hormone Therapy and Cardiovascular Outcomes
Heinrich-Heine University, Duesseldorf 3408 participants Est. completion 2041-03 2 sitesCardiovascular disease Other conditions: Hormone Replacement Therapy, Hormone Replacement Therapy, Post-Menopausal, MenopauseView official trial listing → -
Not yet recruiting NCT NCT07394400
Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.
Milagros Rocha Barajas 94 participants Est. completion 2029-12-31 1 siteOther conditions: Transgender IndividualsView official trial listing → -
Not yet recruiting NCT NCT07394946
Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.
Not yet reported Cancer Care Hospital & Research Centre Foundation, Lahore 126 participants Est. completion 2029-07 1 siteOther conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT07422727
Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy
Not yet reported Sligo General Hospital 40 participants Est. completion 2026-04-01 1 siteOther conditions: Hot Flashes, Sleep, Hormonal, CancerView official trial listing → -
Not yet recruiting NCT NCT07423611
ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer
Not yet reported Fudan University 388 participants Est. completion 2030-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07447024
Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy
Not yet reported Cairo University 60 participants Est. completion 2026-06-15 1 site Stand-aloneOther conditions: MastectomyView official trial listing → -
Not yet recruiting NCT NCT07462663
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
Not yet reported Hospital Universitari de Bellvitge 80 participants Est. completion 2035-01 Stand-aloneOther conditions: Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Obesity & Overweight, BMI>40, Obesity, Obesity Grade IIIView official trial listing → -
Completed NCT NCT07481942
Body Composition Assessment in Transgender Population.
Celia Bañuls 70 participants Est. completion 2025-10-31 1 siteOther conditions: TransgenderView official trial listing → -
Completed NCT NCT07487129
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt
Not yet reported Beni-Suef University 206 participants Est. completion 2025-12-20 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07490509
Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer
Not yet reported Poitiers University Hospital 235 participants Est. completion 2029-09Other conditions: Abemaciclib, Abemaciclib-related Diarrhea, Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07497191
AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer
Shengjing Hospital 300 participants Est. completion 2030-03-05Other conditions: Breast Cancer, Perimenopause, Ovarian ReserveView official trial listing → -
Completed NCT NCT07519213
Guangdong Endometriosis Retrospective Clinical Cohort
Guangdong Women and Children Hospital 1121 participants Est. completion 2026-01-01 1 siteOther conditions: Ovarian Endometrioma, EndometriosisView official trial listing → -
Not yet recruiting NCT NCT07529353
Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .
Not yet reported University of Rochester 20 participants Est. completion 2028-10 1 siteOther conditions: Breast Cancer, Cancer Related FatigueView official trial listing → -
Active, not recruiting NCT NCT07541703
Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer
Spotlight Medical 2200 participants Est. completion 2028-03-31 1 siteOther conditions: Breast Cancer, Early Breast Cancer, ER-Positive HER2-Negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07542964
Transgender Analysis of Nephrological Studies Focused on Renal Metrics
Amsterdam UMC, location VUmc 60 participants Est. completion 2028-09 1 siteOther conditions: Kidney Disease, Kidney Injury, Transgender IndividualsView official trial listing → -
Not yet recruiting NCT NCT07545486
Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment
Chirec 1235 participants Est. completion 2036-06-01 12 sitesOther conditions: Solid TumorView official trial listing → -
Not yet recruiting NCT NCT07562399
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Not yet reported Dana-Farber Cancer Institute 224 participants Est. completion 2028-12-31 4 sitesOther conditions: Medication Adherence, Breast CancerView official trial listing → -
Withdrawn NCT NCT07570966
Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals Est. completion 2031-08-01Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer (mCRPC)View official trial listing → -
Not yet recruiting NCT NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal Women
Not yet reported University Hospital, Toulouse 94 participants Est. completion 2027-12-31 1 siteOther conditions: MenopauseView official trial listing → -
Enrolling by invitation NCT NCT07586319
Effectiveness of Surgery for Improving Survival in Oligometastatic Breast Cancer Patients
Not yet reported Sharif Medical Research Center 110 participants Est. completion 2031-06-01 1 siteOther conditions: Survival OutcomesView official trial listing → -
Not yet recruiting NCT NCT07590583
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-12-02 2 sitesOther conditions: Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Hormone Receptor-Positive Breast Carcinoma, Unresectable Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Not yet recruiting NCT NCT07610733
Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.
Not yet reported Fudan University 100 participants Est. completion 2030-06-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07619066
A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.
Not yet reported MedSIR 25 participants Est. completion 2028-11-28Other conditions: Advanced Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer, HER2 MutationView official trial listing → -
Not yet recruiting NCT NCT07621289
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
University Hospital, Caen 10000 participants Est. completion 2030-12-31Cardiovascular disease Other conditions: Cancer, Anticancer Treatment, Hematological MalignanciesView official trial listing → -
Not yet recruiting NCT NCT07645326
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Not yet reported Georgetown University 108 participants Est. completion 2032-08 1 siteOther conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)View official trial listing → -
Not yet recruiting NCT NCT07668427
The Impact of a Web-based Empowerment Program on Intolerance of Uncertainty and Maintenance Burden.
Not yet reported Necmettin Erbakan University 62 participants Est. completion 2027-05-17Other conditions: Intolerance of Uncertainty, Caregiving BurdenView official trial listing → -
Not yet recruiting NCT NCT07677956
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2036-12-30Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07687225
Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases
Not yet reported West China Hospital 216 participants Est. completion 2036-12-31Other conditions: Breast Cancer, Stage IV Breast Cancer, Bone MetastasesView official trial listing → -
Not yet recruiting NCT NCT07697768
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Not yet reported Patricia Lordelo 150 participants Est. completion 2028-05-20 1 siteOther conditions: Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis, Vulvovaginal Candidiasis (VVC)View official trial listing → -
Not yet recruiting NCT NCT07716046
Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer
Not yet reported Fudan University 240 participants Est. completion 2032-12-31Other conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer, HR+/HER2+ Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07729046
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 siteOther conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07730580
Study of XNW5004 Tablets in Advanced Prostate Cancer
Not yet reported Evopoint Biosciences Inc. 242 participants Est. completion 2028-12-31 Stand-aloneOther conditions: Advanced Prostate CancerView official trial listing → -
Not yet recruiting NCT NCT07738341
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
Not yet reported, Not yet reported Eddingpharm (Zhuhai) Co., Ltd. 270 participants Est. completion 2030-08-01Other conditions: Breast Cancer (Locally Advanced or Metastatic)View official trial listing → -
Not yet recruiting NCT NCT07745257
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
Not yet reported Sun Yat-sen University 40 participants Est. completion 2028-07-28 9 sitesOther conditions: HR-positive, HER2-negative Metastatic Breast Cancer With Brain MetastasesView official trial listing → -
Not yet recruiting NCT NCT07754292
Off-Label Treatment With Immune Checkpoint Inhibitor Blockade
Not yet reported Medical College of Wisconsin 231 participants Est. completion 2036-11-01 1 site Stand-aloneOther conditions: MalignancyView official trial listing → -
Not yet recruiting NCT NCT07759947
Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy
Not yet reported Massachusetts General Hospital 400 participants Est. completion 2031-06-01 2 sitesOther conditions: Hormone Receptor Positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07767448
Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events
Not yet reported Stanford University 50 participants Est. completion 2029-02 1 siteOther conditions: CancerView official trial listing → -
Not yet recruiting NCT NCT07773662
Age of Puberty Onset Among Girls in Asyut, Egypt
Assiut University 600 participants Est. completion 2027-10Other conditions: PubertyView official trial listing → -
Not yet recruiting NCT NCT07782840
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
Not yet reported Hebei Medical University Fourth Hospital 40 participants Est. completion 2028-12-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07786051
DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)
Not yet reported The Netherlands Cancer Institute 80 participants Est. completion 2028-11-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07787520
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sitesOther conditions: Patients With Advanced Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07817446
Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study
Chulalongkorn University 500 participants Est. completion 2027-12-31 1 siteOther conditions: Headache, MigraineView official trial listing → -
Not yet recruiting NCT NCT07833501
Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer
D'Or Institute for Research and Education 172 participants Est. completion 2027-05-30Other conditions: Hormone Receptor-Positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07837063
Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment.
The Clatterbridge Cancer Centre NHS Foundation Trust 40 participants Est. completion 2030-09-03 1 siteOther conditions: Cancer, UrologyView official trial listing → -
Not yet recruiting NCT NCT07840534
Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)
Not yet reported University College Cork 30 participants Est. completion 2028-06-01 1 siteOther conditions: Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy, Early Stage Breast CancerView official trial listing → -
Completed NCT NCT07843121
Supervised Exercise in Women With Breast Cancer
Not yet reported University of Extremadura 16 participants Est. completion 2025-09-23 1 siteOther conditions: Breast Cancer, Breast NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07844759
SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers
Not yet reported Renaissance Institute of Precision Oncology and Radiosurgery 30 participants Est. completion 2032-01-01 1 siteOther conditions: Breast Cancer, Early-Stage Breast Carcinoma, Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07849127
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Not yet reported Women's Heart Austria 800 participants Est. completion 2034-03-31 1 siteCardiovascular disease Other conditions: AtherosclerosesView official trial listing → -
Not yet recruiting NCT NCT07850609
A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)
Not yet reported Merck Sharp & Dohme LLC 80 participants Est. completion 2027-12-02Other conditions: HIVView official trial listing → -
Not yet recruiting NCT NCT07859319
Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting
Not yet reported Hospices Civils de Lyon 105 participants Est. completion 2028-03 3 sitesOther conditions: Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint PainView official trial listing → -
Not yet recruiting NCT NCT07861932
A Phase 1/2a Study of K-1728 in Advanced Solid Tumors
Not yet reported, Not yet reported KymaThera, Inc. 110 participants Est. completion 2029-03Other conditions: Breast Neoplasms, Solid Tumors, PIK3CA Gene MutationView official trial listing → -
Not yet recruiting NCT NCT07867262
A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer
Not yet reported Genentech, Inc. 165 participants Est. completion 2030-08-15Other conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07871396
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females on Hormone Therapy
Not yet reported University of Virginia 24 participants Est. completion 2028-01-30 1 siteOther conditions: Postmenopausal Female Patients, Vasomotor Symptoms, Menopausal Hormone TherapyView official trial listing → -
Not yet recruiting NCT NCT07905001
A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer
Not yet reported Prelude Therapeutics Incorporated 242 participants Est. completion 2029-10-31Other conditions: Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, HR-positive Breast Cancer, HR+/HER2- Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07907653
Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37 participants Est. completion 2035-01 1 siteOther conditions: Prostate Cancer (Adenocarcinoma)View official trial listing → -
Active, not recruiting NCT NCT07909785
AKU Study - Acupuncture for Aromatase Inhibitor-Induced Musculoskeletal Syndrome
Not yet reported Masaryk Memorial Cancer Institute 200 participants Est. completion 2028-03-31 1 siteOther conditions: Aromatase Inhibitor-Associated Musculoskeletal Syndrome, Arthralgia Syndrome, Early Breast Cancer (EBC)View official trial listing → -
Not yet recruiting NCT NCT07911839
Agentic AI App and Home Bioimpedance Monitoring for Endocrine Therapy Adherence and Lymphedema in Breast Cancer Survivors
Not yet reported Chang-Ik Yoon 264 participants Est. completion 2028-12-31 1 siteOther conditions: Breast Neoplasm Malignant Primary, Lymphedema Arm, Medication Adherence, Ductal Carcinoma In SituView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
